<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1d3 20150301//EN" "http://jats.nlm.nih.gov/publishing/1.1d3/JATS-journalpublishing1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.1d3" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">PLoS ONE</journal-id>
<journal-id journal-id-type="publisher-id">plos</journal-id>
<journal-id journal-id-type="pmc">plosone</journal-id>
<journal-title-group>
<journal-title>PLOS ONE</journal-title>
</journal-title-group>
<issn pub-type="epub">1932-6203</issn>
<publisher>
<publisher-name>Public Library of Science</publisher-name>
<publisher-loc>San Francisco, CA USA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1371/journal.pone.0164512</article-id>
<article-id pub-id-type="publisher-id">PONE-D-16-15349</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Research Article</subject>
</subj-group>
<subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Infectious diseases</subject><subj-group><subject>Viral diseases</subject><subj-group><subject>Rotavirus infection</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Anatomy</subject><subj-group><subject>Digestive system</subject><subj-group><subject>Gastrointestinal tract</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Anatomy</subject><subj-group><subject>Digestive system</subject><subj-group><subject>Gastrointestinal tract</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Organisms</subject><subj-group><subject>Viruses</subject><subj-group><subject>RNA viruses</subject><subj-group><subject>Reoviruses</subject><subj-group><subject>Rotavirus</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Microbiology</subject><subj-group><subject>Medical microbiology</subject><subj-group><subject>Microbial pathogens</subject><subj-group><subject>Viral pathogens</subject><subj-group><subject>Reoviruses</subject><subj-group><subject>Rotavirus</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Pathology and laboratory medicine</subject><subj-group><subject>Pathogens</subject><subj-group><subject>Microbial pathogens</subject><subj-group><subject>Viral pathogens</subject><subj-group><subject>Reoviruses</subject><subj-group><subject>Rotavirus</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Organisms</subject><subj-group><subject>Viruses</subject><subj-group><subject>Viral pathogens</subject><subj-group><subject>Reoviruses</subject><subj-group><subject>Rotavirus</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Organisms</subject><subj-group><subject>Bacteria</subject><subj-group><subject>Gut bacteria</subject><subj-group><subject>Bifidobacterium</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Microbiology</subject><subj-group><subject>Probiotics</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Ecology and environmental sciences</subject><subj-group><subject>Extremophiles</subject></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Gastroenterology and hepatology</subject><subj-group><subject>Diarrhea</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Diagnostic medicine</subject><subj-group><subject>Signs and symptoms</subject><subj-group><subject>Diarrhea</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Pathology and laboratory medicine</subject><subj-group><subject>Signs and symptoms</subject><subj-group><subject>Diarrhea</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Immunology</subject><subj-group><subject>Immune response</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Immunology</subject><subj-group><subject>Immune response</subject></subj-group></subj-group></subj-group></article-categories>
<title-group>
<article-title>Study of the Ability of Bifidobacteria of Human Origin to Prevent and Treat Rotavirus Infection Using Colonic Cell and Mouse Models</article-title>
<alt-title alt-title-type="running-head">Anti-Rotavirus Activity of <italic>B</italic>. <italic>thermophilum RBL67</italic></alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" equal-contrib="yes" xlink:type="simple">
<name name-style="western">
<surname>Gagnon</surname>
<given-names>Mélanie</given-names>
</name>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author" equal-contrib="yes" xlink:type="simple">
<name name-style="western">
<surname>Vimont</surname>
<given-names>Allison</given-names>
</name>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Darveau</surname>
<given-names>André</given-names>
</name>
<xref ref-type="aff" rid="aff002"><sup>2</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Fliss</surname>
<given-names>Ismaïl</given-names>
</name>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author" corresp="yes" xlink:type="simple">
<contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0003-2553-4204</contrib-id>
<name name-style="western">
<surname>Jean</surname>
<given-names>Julie</given-names>
</name>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
<xref ref-type="corresp" rid="cor001">*</xref>
</contrib>
</contrib-group>
<aff id="aff001"><label>1</label> <addr-line>Institute of Nutrition and Functional Foods, Department of Food Science, Laval University, Quebec, Quebec, Canada</addr-line></aff>
<aff id="aff002"><label>2</label> <addr-line>Department of Biochemistry, Microbiology and Bioinformatics, Laval University, Quebec, Quebec, Canada</addr-line></aff>
<contrib-group>
<contrib contrib-type="editor" xlink:type="simple">
<name name-style="western">
<surname>Iturriza-Gómara</surname>
<given-names>Miren</given-names>
</name>
<role>Editor</role>
<xref ref-type="aff" rid="edit1"/>
</contrib>
</contrib-group>
<aff id="edit1"><addr-line>University of Liverpool, UNITED KINGDOM</addr-line></aff>
<author-notes>
<fn fn-type="conflict" id="coi001">
<p>The authors have declared that no competing interests exist.</p>
</fn>
<fn fn-type="con">
<p><list list-type="simple"><list-item><p><bold>Conceptualization:</bold> AD IF JJ.</p></list-item> <list-item><p><bold>Data curation:</bold> MG AV.</p></list-item> <list-item><p><bold>Formal analysis:</bold> MG AV.</p></list-item> <list-item><p><bold>Funding acquisition:</bold> JJ.</p></list-item> <list-item><p><bold>Investigation:</bold> MG.</p></list-item> <list-item><p><bold>Methodology:</bold> MG AD IF JJ.</p></list-item> <list-item><p><bold>Project administration:</bold> AD IF JJ.</p></list-item> <list-item><p><bold>Resources:</bold> AD IF JJ.</p></list-item> <list-item><p><bold>Software:</bold> SB CE HA YZL.</p></list-item> <list-item><p><bold>Supervision:</bold> YZL.</p></list-item> <list-item><p><bold>Validation:</bold> MG AV AD IF JJ.</p></list-item> <list-item><p><bold>Visualization:</bold> MG AV.</p></list-item> <list-item><p><bold>Writing – original draft:</bold> MG AV.</p></list-item> <list-item><p><bold>Writing – review &amp; editing:</bold> MG AV JJ.</p></list-item></list></p>
</fn>
<corresp id="cor001">* E-mail: <email xlink:type="simple">julie.jean@fsaa.ulaval.ca</email></corresp>
</author-notes>
<pub-date pub-type="epub">
<day>11</day>
<month>10</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="collection">
<year>2016</year>
</pub-date>
<volume>11</volume>
<issue>10</issue>
<elocation-id>e0164512</elocation-id>
<history>
<date date-type="received">
<day>15</day>
<month>4</month>
<year>2016</year>
</date>
<date date-type="accepted">
<day>25</day>
<month>9</month>
<year>2016</year>
</date>
</history>
<permissions>
<copyright-year>2016</copyright-year>
<copyright-holder>Gagnon et al</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/" xlink:type="simple">
<license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/" xlink:type="simple">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p>
</license>
</permissions>
<self-uri content-type="pdf" xlink:href="info:doi/10.1371/journal.pone.0164512"/>
<abstract>
<p>Rotavirus is the leading cause of severe acute gastroenteritis among children worldwide. Despite effective vaccines, inexpensive alternatives such as probiotics are needed. The aim of this study was to assess the ability of probiotic candidate <italic>Bifidobacterium thermophilum</italic> RBL67 to inhibit rotavirus infection. Bacterial adhesion to intestinal cells and interference with viral attachment were evaluated <italic>in vitro</italic>. <italic>B</italic>. <italic>thermophilum</italic> RBL67 displayed adhesion indexes of 625 ± 84 and 1958 ± 318 on Caco-2 and HT-29 cells respectively and was comparable or superior to four other bifidobacteria, including <italic>B</italic>. <italic>longum</italic> ATCC 15707 and <italic>B</italic>. <italic>pseudolongum</italic> ATCC 25526 strains. Incubation of <italic>B</italic>. <italic>thermophilum</italic> RBL67 for 30 min before (exclusion) and simultaneously (competition) with human rotavirus strain Wa decreased virus attachment by 2.0 ± 0.1 and 1.5 ± 0.1 log<sub>10</sub> (by 99.0% and 96.8% respectively). Displacement of virus already present was negligible. In CD-1 suckling mice fed <italic>B</italic>. <italic>thermophilum</italic> RBL67 challenged with simian rotavirus SA-11, pre-infection feeding with RBL 67 was more effective than post-infection feeding, reducing the duration of diarrhea, limiting epithelial lesions, reducing viral replication in the intestine, accelerating recovery, and stimulating the humoral specific IgG and IgM response, without inducing any adverse effect. <italic>B</italic>. <italic>thermophilum</italic> RBL67 had little effect on intestinal IgA titer. These results suggest that humoral immunoglobulin might provide protection against the virus and that <italic>B</italic>. <italic>thermophilum</italic> RBL67 has potential as a probiotic able to inhibit rotavirus infection and ultimately reduce its spread.</p>
</abstract>
<funding-group>
<award-group id="award001">
<funding-source>
<institution>Fonds de Recherche du Québec - Nature et Technologies (CA)</institution>
</funding-source>
<award-id>FR068242</award-id>
<principal-award-recipient>
<name name-style="western">
<surname>Fliss</surname>
<given-names>Ismaïl</given-names>
</name>
</principal-award-recipient>
</award-group>
<award-group id="award002">
<funding-source>
<institution>Fonds de Recherche du Québec - Nature et Technologies (CA)</institution>
</funding-source>
<award-id>Scholarship B2</award-id>
<principal-award-recipient>
<name name-style="western">
<surname>Gagnon</surname>
<given-names>Mélanie</given-names>
</name>
</principal-award-recipient>
</award-group>
<funding-statement>This work was supported by Fonds de Recherche du Québec - Nature et Technologies, FR068242, to Dr. Ismaïl Fliss, and Fonds de Recherche du Québec - Nature et Technologies, Scholarship B2, to Dr. Mélanie Gagnon. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</funding-statement>
</funding-group>
<counts>
<fig-count count="6"/>
<table-count count="1"/>
<page-count count="18"/>
</counts>
<custom-meta-group>
<custom-meta id="data-availability">
<meta-name>Data Availability</meta-name>
<meta-value>All relevant data are within the paper and its Supporting Information files.</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<sec id="sec001" sec-type="intro">
<title>Introduction</title>
<p>Human rotavirus is the leading cause of severe dehydrating diarrhea in infants and young children worldwide, in both developed and developing countries. Peak incidence occurs in children 2 years of age and under, with an estimated 0.3 rotavirus-induced gastroenteritis episode per child-year [<xref ref-type="bibr" rid="pone.0164512.ref001">1</xref>]. Between 1990 and 2011, rotavirus infection caused an estimated 197,000 deaths per year, or 23 per hour [<xref ref-type="bibr" rid="pone.0164512.ref002">2</xref>]. About 90% of these occurred in low-income countries in Africa and Asia and were associated with poor health care [<xref ref-type="bibr" rid="pone.0164512.ref003">3</xref>]. The virus is transmitted primarily via the fecal-oral route and to a lesser extent via vomit, spreading via contaminated food or water, direct person-to-person contact, aerosols, and environmental surfaces [<xref ref-type="bibr" rid="pone.0164512.ref004">4</xref>]. Infectious doses as low as one plaque-forming unit [<xref ref-type="bibr" rid="pone.0164512.ref005">5</xref>], viral loads as high as 10<sup>12</sup> particles per gram in feces and vomit [<xref ref-type="bibr" rid="pone.0164512.ref004">4</xref>] and persistence on fomites and hands [<xref ref-type="bibr" rid="pone.0164512.ref006">6</xref>, <xref ref-type="bibr" rid="pone.0164512.ref007">7</xref>] all contribute to the high incidence of rotavirus illness. Since the spread of the virus is very difficult to control, rotavirus outbreaks occur often in crowded locations such as daycare centers, hospitals and schools [<xref ref-type="bibr" rid="pone.0164512.ref004">4</xref>]. Rotavirus infects primarily mature enterocytes in the intestinal epithelium, leading to malabsorption and osmotic diarrhea [<xref ref-type="bibr" rid="pone.0164512.ref008">8</xref>, <xref ref-type="bibr" rid="pone.0164512.ref009">9</xref>].</p>
<p>Since no specific anti-rotavirus therapy is currently available, the main treatment is fluid replacement to prevent dehydration and zinc treatment to decrease the severity and duration of the diarrhea [<xref ref-type="bibr" rid="pone.0164512.ref003">3</xref>]. Two effective rotavirus vaccines, namely RotaTeq<sup>®</sup> (Merck and Co) and Rotarix<sup>®</sup> (GSK Biologicals), have been available since 2006 and are recommended by the World Health Organization for use in all countries, particularly in those where diarrhea-related mortality in children younger than 5 years is common [<xref ref-type="bibr" rid="pone.0164512.ref003">3</xref>]. The number of countries that have introduced rotavirus vaccines increased from 5 in 2011 to 35 in 2015 [<xref ref-type="bibr" rid="pone.0164512.ref010">10</xref>]. Both vaccines have been reported to be highly effective in high-income settings [<xref ref-type="bibr" rid="pone.0164512.ref011">11</xref>]. Nevertheless, the protection afforded by these live oral vaccines is reduced in low-income settings [<xref ref-type="bibr" rid="pone.0164512.ref012">12</xref>]. Consequently, inexpensive and effective supplementary or complementary therapies remain necessary.</p>
<p>The role of intestinal microbiota in modulating enteric viral infections has been highlighted by several recent studies [<xref ref-type="bibr" rid="pone.0164512.ref013">13</xref>, <xref ref-type="bibr" rid="pone.0164512.ref014">14</xref>], in particular with norovirus [<xref ref-type="bibr" rid="pone.0164512.ref015">15</xref>] and rotavirus [<xref ref-type="bibr" rid="pone.0164512.ref016">16</xref>]. In this context, the use of probiotic strains as an alternative therapy has been proposed [<xref ref-type="bibr" rid="pone.0164512.ref017">17</xref>, <xref ref-type="bibr" rid="pone.0164512.ref018">18</xref>]. Based on consultation with scientific experts, the World Health Organization in 2001 retained the following (and current) definition of probiotics: “live microorganisms that, when administered in adequate amounts, confer a health benefit on the host” [<xref ref-type="bibr" rid="pone.0164512.ref019">19</xref>]. General benefits associated with probiotics include support of a healthy gut microbiota, a healthy digestive tract and a healthy immune system [<xref ref-type="bibr" rid="pone.0164512.ref020">20</xref>]. More precisely, some probiotic strains have been shown to stimulate gut epithelial cell proliferation significantly, to reduce gut permeability and to enhance immune responses as well as providing other health benefits [<xref ref-type="bibr" rid="pone.0164512.ref021">21</xref>–<xref ref-type="bibr" rid="pone.0164512.ref023">23</xref>]. Decreased duration, severity or incidence of infantile diarrhea has been noted in some pediatric clinical trials in conjunction with rotavirus outbreaks. Several probiotic strains have been tested, including the Gram-positive strains of <italic>Bifidobacterium animalis</italic> subsp. <italic>lactis</italic> Bb12 [<xref ref-type="bibr" rid="pone.0164512.ref024">24</xref>], <italic>Lactobacillus rhamnosus</italic> GG [<xref ref-type="bibr" rid="pone.0164512.ref025">25</xref>, <xref ref-type="bibr" rid="pone.0164512.ref026">26</xref>], <italic>Lb</italic>. <italic>paracasei</italic> [<xref ref-type="bibr" rid="pone.0164512.ref027">27</xref>], <italic>B</italic>. <italic>bifidum</italic>, <italic>Streptococcus thermophilus</italic> [<xref ref-type="bibr" rid="pone.0164512.ref028">28</xref>], and recently the Gram-negative <italic>Escherichia coli</italic> Nissle [<xref ref-type="bibr" rid="pone.0164512.ref029">29</xref>]. The beneficial effects of probiotics are thought to be bacterial species specific, although the precise mechanisms involved in these effects remain largely unknown [<xref ref-type="bibr" rid="pone.0164512.ref027">27</xref>, <xref ref-type="bibr" rid="pone.0164512.ref030">30</xref>], thus calling for the use of <italic>in vitro</italic> and <italic>in vivo</italic> models.</p>
<p>The probiotic candidate <italic>Bifidobacterium thermophilum</italic> RBL67 used in this study was isolated previously from stool samples obtained from breast-fed infants during research conducted by our group [<xref ref-type="bibr" rid="pone.0164512.ref031">31</xref>, <xref ref-type="bibr" rid="pone.0164512.ref032">32</xref>]. Such infants are known to be less affected by infections such as gastroenteritis [<xref ref-type="bibr" rid="pone.0164512.ref033">33</xref>]. The safety of bifidobacteria for use as probiotics is presumed on the basis of the long historical consumption of fermented milks and ever-growing knowledge on the taxonomy and physiology of the bacteria they contain [<xref ref-type="bibr" rid="pone.0164512.ref034">34</xref>, <xref ref-type="bibr" rid="pone.0164512.ref035">35</xref>]. Moderately tolerant of oxygen and low pH [<xref ref-type="bibr" rid="pone.0164512.ref032">32</xref>], <italic>B</italic>. <italic>thermophilum</italic> RBL67 appears resistant to only one antibiotic (nalidixic acid), and is sensitive to nine antibiotics including ampicillin, tetracycline and chloramphenicol [<xref ref-type="bibr" rid="pone.0164512.ref036">36</xref>]. It reportedly produces a bacteriocin-like substance active against <italic>Listeria</italic> and <italic>Salmonella</italic> [<xref ref-type="bibr" rid="pone.0164512.ref031">31</xref>, <xref ref-type="bibr" rid="pone.0164512.ref032">32</xref>, <xref ref-type="bibr" rid="pone.0164512.ref037">37</xref>, <xref ref-type="bibr" rid="pone.0164512.ref038">38</xref>] and protects epithelial integrity upon <italic>Salmonella</italic> challenge in the presence of competing human microbiota [<xref ref-type="bibr" rid="pone.0164512.ref039">39</xref>]. Its strong anti-<italic>Salmonella</italic> activity has been demonstrated in an <italic>in vitro</italic> continuous fermentation system simulating the juvenile intestinal ecosystem, along with its ability to rebalance the metabolic activity of gut microbiota after antibiotic treatment [<xref ref-type="bibr" rid="pone.0164512.ref038">38</xref>]. Its genome has been sequenced [<xref ref-type="bibr" rid="pone.0164512.ref040">40</xref>] and is available for genetic studies.</p>
<p>The aim of the present study was to evaluate the adhesiveness of <italic>B</italic>. <italic>thermophilum</italic> RBL67 to Caco-2 and HT-29 cells as well as its ability to interfere with rotavirus attachment. An <italic>in vivo</italic> study using suckling mice was also performed to assess its host-protection properties under intestinal conditions and its impact on the course of rotavirus infection, including diarrhea, virus replication, colon histology and the immune response.</p>
</sec>
<sec id="sec002" sec-type="materials|methods">
<title>Materials and Methods</title>
<sec id="sec003">
<title>Bacterial strains</title>
<p>Three strains of <italic>Bifidobacterium</italic> from the Research Network on Lactic Acid Bacteria (RBL Network) were used in this study, namely <italic>B</italic>. <italic>thermophilum</italic> RBL67, <italic>B</italic>. <italic>thermacidophilum</italic> RBL69 and <italic>B</italic>. <italic>thermacidophilum</italic> RBL70, isolated from stool samples obtained from infants [<xref ref-type="bibr" rid="pone.0164512.ref031">31</xref>, <xref ref-type="bibr" rid="pone.0164512.ref032">32</xref>] and preselected on the basis of resistance to gastrointestinal conditions. Two <italic>Bifidobacterium</italic> strains obtained from the American Type Culture Collection were used for comparison purposes: <italic>B</italic>. <italic>longum</italic> ATCC 15707 and <italic>B</italic>. <italic>pseudolongum</italic> ATCC 25526. All strains were cultured in MRS agar supplemented with 0.05% (wt/vol) L-cysteine-hydrochloride at 37°C under anaerobic conditions as described previously [<xref ref-type="bibr" rid="pone.0164512.ref041">41</xref>] and enumerated (in colony-forming units, cfu) on Beerens agar plates [<xref ref-type="bibr" rid="pone.0164512.ref042">42</xref>].</p>
</sec>
<sec id="sec004">
<title>Cell cultures</title>
<p>All cell lines were cultured in Gibco media (Invitrogen, Burlington, Ontario, Canada) at 37°C under a 5% CO<sub>2</sub> atmosphere. Caco-2 cells (ATCC HTB-37) were grown routinely in Dulbecco’s Modified Eagle medium as described previously [<xref ref-type="bibr" rid="pone.0164512.ref041">41</xref>]. HT-29 cells (ATCC HTB-38) were grown routinely in RPMI 1640 medium supplemented with 10% fetal bovine serum (FBS), 2 mmol/L L-glutamine, 100 U/mL penicillin and 100 μg/mL streptomycin. Rhesus monkey kidney cell line MA-104 (ATCC CRL-2378.1) was routinely grown in Eagle’s minimal essential medium supplemented with 10% FBS, 2 mmol/L L-glutamine, 1% nonessential amino acids, 1% HEPES buffer, 1.125 g/L sodium bicarbonate, 100 U/mL penicillin and 100 μg/mL streptomycin. For adhesion and inhibition assays, monolayers of human colon carcinoma cells (Caco-2 and HT-29) were seeded at a density of 10<sup>4</sup> cells per well in 24-well tissue culture plates (Falcon, Becton Dickinson and Co., Franklin Lakes, NJ). The culture medium was replaced every day, and the monolayer was used at post-confluence (10<sup>6</sup> cells/well) after 15 and 21 days for Caco-2 and HT-29 respectively. The medium was replaced with its antibiotic-free equivalent 18 h before performing the assays.</p>
</sec>
<sec id="sec005">
<title>Viruses</title>
<p>Human rotavirus strain Wa (ATCC VR-2018) and simian rotavirus strain SA-11 (ATCC VR-1565) used for <italic>in vitro</italic> and <italic>in vivo</italic> assays, respectively, were propagated in MA-104 cells as described previously [<xref ref-type="bibr" rid="pone.0164512.ref006">6</xref>] with some modifications. Briefly, confluent cell monolayers were infected at an MOI of 1.5 with rotavirus pre-activated with 16 μg/mL of porcine trypsin (Sigma Chemical Co., St. Louis, MO) for 30 min at room temperature. After adsorption (1 h at 37°C), maintenance medium (MEM + 2% FBS) was added and cells were incubated for 48 h at 37°C with 5% CO<sub>2</sub>. The infected cultures were then frozen (-80°C) and thawed (37°C) three times, the contents centrifuged at 1,000 x g for 10 min and the supernatant dispensed into vials for storage at -80°C until use. Infectious viruses were quantified using the following cell based methods. Strain Wa titer was determined from a cell culture immunofluorescence assay [<xref ref-type="bibr" rid="pone.0164512.ref043">43</xref>] and expressed in focus-forming units (ffu) per mL. The titer of simian rotavirus strain SA-11 was determined by plaque assay [<xref ref-type="bibr" rid="pone.0164512.ref044">44</xref>] with some modifications and expressed in plaque-forming units (pfu) per mL. Briefly, confluent MA-104 cells in 6-well plates were washed with phosphate-buffered saline (PBS) and infected with 100 μL of pre-activated SA-11 at 37°C for 1 h in a 5% CO<sub>2</sub> atmosphere. Monolayers were then overlaid with MEM supplemented with 4% FBS, 1.2% agarose type II (Sigma) and 6.5 μg/mL trypsin. Plates were incubated for 3 days at 37°C (5% CO<sub>2</sub>), fixed in 3.7% (v/v) formaldehyde and then stained with 0.1% (w/v) aqueous crystal violet solution to reveal lytic plaques resulting from the cytopathic effect.</p>
</sec>
<sec id="sec006">
<title><italic>In vitro</italic> adhesion of <italic>Bifidobacterium</italic> strains to Caco-2 and HT-29 cells</title>
<p>Cells monolayers were washed twice with sterile PBS, drained, contacted with 250 μL of <italic>Bifidobacterium</italic> suspension (5×10<sup>9</sup> cfu/mL in PBS) per well, incubated for 60 min at 37°C under anaerobic conditions, then rinsed with PBS. Adherent bacteria were then collected in three washings of the monolayer with PBS after 15 min of trypsin-EDTA treatment at 37°C and enumerated by plating. Results are expressed as the adhesion index, which is the number of bacteria adhering per 100 cells.</p>
</sec>
<sec id="sec007">
<title><italic>In vitro</italic> antagonism against rotavirus attachment to Caco-2 and HT-29 cells</title>
<p>Cell monolayers were washed twice with sterile PBS, drained, then contacted with 250 μL of pre-activated human rotavirus strain Wa suspension (5×10<sup>6</sup> ffu/mL) per well for 30 min after (exclusion), simultaneously with (competition) or 30 min before (displacement) the addition of 250 μL of <italic>B</italic>. <italic>thermophilum</italic> RBL67 suspension (5×10<sup>9</sup> cfu/mL) per well. Positive controls received PBS instead of <italic>B</italic>. <italic>thermophilum</italic> RBL67. Cells were then incubated for 90 min at 37°C under anaerobic conditions, rinsed with PBS, and attached virus was collected in three washings with PBS by repeated pipetting after 15 min of trypsin-EDTA treatment at 37°C. Attached virus was enumerated by cell culture immunofluorescence assay as described previously [<xref ref-type="bibr" rid="pone.0164512.ref043">43</xref>].</p>
</sec>
<sec id="sec008">
<title>Mice</title>
<p>Timed pregnant CD-1 mice obtained from Charles River (St-Constant, Québec, Canada) were fed a standard laboratory rodent chow (Charles River Laboratories, Wilmington, MA), provided with water ad libitum, and kept in an animal room maintained at 22 ± 2°C with a 12 h light/dark cycle. Each dam and its litter were housed in a micro-isolator cage (Lab Products, Seaford, DE) on a cage ventilation rack (Lab Products) that provided a unidirectional flow of filtered air over the cage hoods. All dams were rotavirus antibody negative as measured by enzyme-linked immunosorbent assay (ELISA, described below). The experiments were performed with the approval of the animal care committee of Laval University “Comités de protection des animaux” (SIRUL number: 76543) and the mice were cared for and handled in conformity with the Canadian Guide for the Care and Use of Laboratory Animals [<xref ref-type="bibr" rid="pone.0164512.ref045">45</xref>]. No animal died during the study except for the euthanasia scheduled for the taking of biological samples.</p>
</sec>
<sec id="sec009">
<title>Suckling mice treatment groups</title>
<p>Three experimental repetitions were done using pups from the litters of fifteen dams (10–14 pups per litter, total n = 189). Experiments were conducted on suckling mice because preliminary assays shown that adults mice are highly resistant to rotavirus infection and required either antibiotic pretreatment or a genetically modified mice model. Dams and their litters were assigned randomly to one of the five experimental groups (<xref ref-type="table" rid="pone.0164512.t001">Table 1</xref>). <italic>B</italic>. <italic>thermophilum</italic> RBL67 was given orally at a daily dose of 1×10<sup>9</sup> cfu in 20 μL of PBS for 7 consecutive days, from the age of 3 days or 9 days depending on the experimental group. On day 9, simian rotavirus strain SA-11 not trypsin-activated was given orally at a single dose of 1×10<sup>4</sup> pfu in 20 μL of PBS with 10% blue food coloring (McCormick Co., London, Ontario, Canada) added as a tracer instead of human rotavirus Wa which is noninfectious to mice. Control animals received 20 μL of placebo (PBS with 10% blue food coloring). After each feeding and infection, the pups were returned to their mothers and allowed to suckle. Activity level, body weight and external signs of disease (diarrhea, dehydration) of mice were observed daily over the course of experiment. Mice were sacrificed under anesthesia by intraperitoneal injection of 0.01 mL/g of a ketamine/xylazine mixture (respectively 15 mg/mL and 1 mg/ml) for microbial and histological analysis and measurement of the immune response. All efforts were made to minimize animal suffering.</p>
<table-wrap id="pone.0164512.t001" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0164512.t001</object-id>
<label>Table 1</label> <caption><title>Distribution of experimental groups in the <italic>in vivo</italic> assay.</title></caption>
<alternatives>
<graphic id="pone.0164512.t001g" mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0164512.t001" xlink:type="simple"/>
<table>
<colgroup>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
</colgroup>
<thead>
<tr>
<th align="center"/>
<th align="center" colspan="2"><italic>B</italic>. <italic>thermophilum</italic> RBL67</th>
<th align="center">Simian rotavirus strain SA-11</th>
</tr>
<tr>
<th align="center">Group</th>
<th align="center">Feeding period (days)</th>
<th align="center">Daily dose (cfu/mouse)</th>
<th align="center">Inoculum on day 9 (pfu/mouse)</th>
</tr>
</thead>
<tbody>
<tr>
<td align="center">A</td>
<td align="center">-</td>
<td align="center">-</td>
<td align="center">Control treatment</td>
</tr>
<tr>
<td align="center">B</td>
<td align="center">3–9</td>
<td align="center">10<sup>9</sup></td>
<td align="center">Control treatment</td>
</tr>
<tr>
<td align="center">C</td>
<td align="center">-</td>
<td align="center">-</td>
<td align="center">10<sup>4</sup></td>
</tr>
<tr>
<td align="center">D</td>
<td align="center">3–9</td>
<td align="center">10<sup>9</sup></td>
<td align="center">10<sup>4</sup></td>
</tr>
<tr>
<td align="center">E</td>
<td align="center">9–15</td>
<td align="center">10<sup>9</sup></td>
<td align="center">10<sup>4</sup></td>
</tr>
</tbody>
</table>
</alternatives>
</table-wrap>
</sec>
<sec id="sec010">
<title>Enumeration of intestinal bifidobacteria and rotavirus</title>
<p>The intestines were removed aseptically from the sacrificed mice, weighed, placed in 1.0 mL of PBS with 5% antibiotic solution (for viral counts) or 0.5 g/L L-cysteine (for bacterial counts) and homogenized with an Ultra-Turrax (Janke and Kunkel, Staufen, Germany) on ice for 15 s at 13,500 rpm. For viral quantification, the suspension was then centrifuged at 13,500 rpm for 5 min to remove debris and frozen at -20°C until plaque assay. For bacterial quantification, the suspension was diluted immediately, plated on Beerens selective agar and incubated at 37°C for 72 h under anaerobic conditions. Isolates were then confirmed by Gram staining to be Gram-positive rods and identified using API 50CH galleries (BioMérieux, Montréal, Québec, Canada) according to the manufacturer’s instructions.</p>
</sec>
<sec id="sec011">
<title>Histological analysis of the colon</title>
<p>Sections of colon were fixed in PBS containing 4% (w/v) paraformaldehyde (TAAB, Callera Park, Aldermaston Berks, England), embedded in paraffin, cut into 5 μm slices using a microtome (Model 2040, Reichert-Jung, Vienna, Austria) and stained with hematoxylin and eosin. A pathologist kept unaware of sample origin then examined the epithelium morphology using a light microscope (Leica Microsystems, Richmond Hill, Ontario, Canada). Images were acquired by a Hyper HAD camera (Sony Ltd., Willowdale, Ontario, Canada) and Image Matrox Inspector software 3.1 (Matrox Electronic Systems Ltd., Dorval, Québec, Canada).</p>
</sec>
<sec id="sec012">
<title>Quantification of the immune response in intestinal and serum samples by ELISA</title>
<p>The level of intestinal rotavirus-specific IgA was determined by ELISA as described previously [<xref ref-type="bibr" rid="pone.0164512.ref046">46</xref>, <xref ref-type="bibr" rid="pone.0164512.ref047">47</xref>] with some modifications. Briefly, simian rotavirus strain SA-11 was fixed in a 96-well plate (8×10<sup>5</sup> pfu/mL in 2% formaldehyde-PBS solution). Diluted intestinal homogenate (500 mg/mL) was added, followed by peroxidase-labeled goat anti-mouse IgA and finally the O-phenylenediamine (OPD, Sigma) standard solution in the presence of H<sub>2</sub>O<sub>2</sub>. Optical density (OD) was measured at 450 nm on a Thermomax microplate reader (Molecular Devices, Opti-Ressources, Charny, Québec, Canada). Rotavirus-specific IgG and IgM in serum obtained by centrifuging (4,000 × g for 10 min at 4°C) cardiac blood from individual mice were determined using the same protocol except that peroxidase-conjugated goat anti-mouse (H+L, Kirkegaard and Perry Laboratories) was used. Intestinal fluid and serum from non-infected mice not fed <italic>Bifidobacterium</italic> were used as negative controls on each plate. Titers were calculated as log<sub>10</sub> (1/Dc) where the cut-off dilution (Dc) was the dilution yielding twice the absorbance of the negative controls.</p>
</sec>
<sec id="sec013">
<title>Statistical analyses</title>
<p>Adhesion indexes of <italic>Bifidobacterium</italic> strains and attachment of human rotavirus strain Wa to intestinal cells were compared among treatments using the one-way analysis of variance (ANOVA) general linear model followed by Tukey’s HSD test. Body weight, simian rotavirus strain SA-11 titer, intestinal <italic>B</italic>. <italic>thermophilum</italic> RBL67 count and immunoglobulin concentration were compared among treatment groups using the one-way ANOVA general linear model followed by the Hsu-Dunnett test. Statistical significance was declared at <italic>P</italic> &lt; 0.05. All statistical analyses were performed using JMP<sup>®</sup> software version 10.0 (SAS Institute Inc, Cary, NC).</p>
</sec>
</sec>
<sec id="sec014" sec-type="results">
<title>Results</title>
<sec id="sec015">
<title><italic>B</italic>. <italic>thermophilum</italic> RBL67 displayed high adhesion ability to intestinal cells</title>
<p>The ability of <italic>B</italic>. <italic>thermophilum</italic> RBL67 to adhere to Caco-2 and HT-29 cells was compared with that of four other <italic>Bifidobacterium</italic> strains including two <italic>B</italic>. <italic>thermacidophilum</italic> strains isolated from infant stool samples (RBL69 and RBL70) and two reference strains, namely <italic>B</italic>. <italic>longum</italic> ATCC 15707 and <italic>B</italic>. <italic>pseudolongum</italic> ATCC 25526 (<xref ref-type="fig" rid="pone.0164512.g001">Fig 1</xref>), recognized for their weak and strong adhesion respectively [<xref ref-type="bibr" rid="pone.0164512.ref048">48</xref>]. The adhesion index of <italic>B</italic>. <italic>thermophilum</italic> RBL67 was evaluated at 625 ± 84 and 1958 ± 318 on Caco-2 and HT-29 respectively. Expressed per unit area, <italic>B</italic>. <italic>thermophilum</italic> RBL67 adhesion was 3.3 ± 0.4 x 10<sup>4</sup> cfu/mm² and 1.0 ± 0.2 x 10<sup>5</sup> cfu/mm² to Caco-2 and HT-29 respectively. No significant difference was noted between <italic>B</italic>. <italic>thermophilum</italic> RBL67, RBL69, RBL70 and <italic>B</italic>. <italic>pseudolongum</italic> ATCC 25526. As expected, <italic>B</italic>. <italic>longum</italic> ATCC 15707 showed significantly lower adhesion indexes of 54 ± 97 and 150 ± 318 respectively on Caco-2 and HT-29.</p>
<fig id="pone.0164512.g001" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0164512.g001</object-id>
<label>Fig 1</label>
<caption>
<title>Adhesion of <italic>Bifidobacterium</italic> strains RBL67 (<italic>thermophilum</italic>), RBL69 and RBL70 (<italic>thermacidophilum</italic>), ATCC 15707 (<italic>longum</italic>), and ATCC 25526 (<italic>pseudolongum</italic>) to cultured intestinal cell monolayers: (A) Caco-2, (B) HT-29.</title>
<p>Adherent bacteria were counted by plating after 1 h of contact. Index is the number per 100 intestinal cells. Error bars indicate the standard error of the mean. Different letters indicate significant difference between assays (Tukey’s HSD test, <italic>P</italic> &lt; 0.05, n = 3).</p>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0164512.g001" xlink:type="simple"/>
</fig>
</sec>
<sec id="sec016">
<title><italic>B</italic>. <italic>thermophilum</italic> RBL67 decreased rotavirus attachment to intestinal cells <italic>in vitro</italic></title>
<p>Inhibition of rotavirus attachment to intestinal cells by <italic>B</italic>. <italic>thermophilum</italic> RBL67 was evaluated using exclusion, competition and displacement assays (<xref ref-type="fig" rid="pone.0164512.g002">Fig 2</xref>). Preliminary 48-h trials indicated that the highest attachment to both intestinal cell lines was obtained after 1.5 h of contact time (<xref ref-type="supplementary-material" rid="pone.0164512.s001">S1 Fig</xref>). When rotavirus was added alone (positive control), 5.8 ± 0.1 and 5.7 ± 0.1 log<sub>10</sub> were attached to Caco-2 and HT-29 cell lines respectively. However, when rotavirus was added 30 min after the addition of <italic>B</italic>. <italic>thermophilum</italic> RBL67 (exclusion), the number of viruses attached dropped by two log cycles (to 3.8 ± 0.1). No significant difference between cell lines was observed (<italic>P</italic> &gt; 0.05). In competition and displacement assays, rotavirus attachment was respectively 4.3 ± 0.1 log<sub>10</sub> and 5.6 ± 0.1 log<sub>10</sub>.</p>
<fig id="pone.0164512.g002" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0164512.g002</object-id>
<label>Fig 2</label>
<caption>
<title>Attachment of human rotavirus strain Wa to Caco-2 (A) and HT-29 (B) cells in exclusion, competition and displacement assays with <italic>B</italic>. <italic>thermophilum</italic> RBL67.</title>
<p>Positive controls were contacted with rotavirus only. Attached rotavirus titer was measured by immunofluorescence after 1.5 h of contact and expressed in focus-forming units per mm². Error bars indicate the standard error of the mean. Different letters indicate significant difference between assays (Tukey’s HSD test, <italic>P</italic> &lt; 0.05, n = 3).</p>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0164512.g002" xlink:type="simple"/>
</fig>
</sec>
<sec id="sec017">
<title>Intestinal concentration of <italic>Bifidobacterium</italic> strain RBL67 was not influenced by rotavirus infection</title>
<p>The protective effect of <italic>B</italic>. <italic>thermophilum</italic> RBL67 observed <italic>in vitro</italic> was evaluated in suckling CD-1 mice distributed to five experimental groups (A to E, <xref ref-type="table" rid="pone.0164512.t001">Table 1</xref>). Viable counts of <italic>Bifidobacterium</italic> in the intestinal contents were monitored for 72 h (<xref ref-type="fig" rid="pone.0164512.g003">Fig 3</xref>). In control mice (group A), bifidobacteria were detected at about 3.8 log<sub>10</sub> cfu/g, which remained stable throughout the experiment. Similar results (P &gt; 0.05) were obtained with mice challenged with rotavirus (group C). In mice fed <italic>B</italic>. <italic>thermophilum</italic> RBL67 then challenged with rotavirus (group D), <italic>Bifidobacterium</italic> counts gradually decreased from 7.5 to 4.2 log<sub>10</sub> cfu/g and were no longer significantly different from control mice after 48 h. In contrast, counts increased from 4.2 to 6.6 log<sub>10</sub> cfu/g in mice that received <italic>B</italic>. <italic>thermophilum</italic> RBL67 for 7 days after challenge (group E) and were significantly higher than in control mice starting at 24 h.</p>
<fig id="pone.0164512.g003" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0164512.g003</object-id>
<label>Fig 3</label>
<caption>
<title><italic>Bifidobacterium</italic> viable counts over a 72 h period in the intestinal contents of suckling CD-1 mice: not fed strain RBL67 (group A, ◆), fed strain RBL67 (group B, ▴), not fed strain RBL67, challenged with rotavirus SA-11 (group C, ✕), fed strain RBL67 before challenge (group D, ■), fed strain RBL67 after challenge (group E, ●) (See <xref ref-type="table" rid="pone.0164512.t001">Table 1</xref> for details) <italic>Bifidobacterium</italic> counts were determined by plating.</title>
<p>Error bars indicate the standard error of the mean. An asterisk indicates significant difference compared to <bold>◆</bold> (Hsu-Dunnett test, <italic>P</italic> &lt; 0.05, n = 3).</p>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0164512.g003" xlink:type="simple"/>
</fig>
</sec>
<sec id="sec018">
<title>Bifidobacterium strain RBL67 fed prior to challenge reduced diarrhea duration</title>
<p>Control mice (group A) did not develop diarrhea at any point. Mice challenged with the simian rotavirus strain SA-11 without receiving <italic>B</italic>. <italic>thermophilum</italic> RBL67 (group C) suffered from diarrhea beginning at 24–30 h post challenge and most intensely at 54 h. Reduced activity was observed during the 7 days post challenge. In contrast, mice that received <italic>B</italic>. <italic>thermophilum</italic> RBL67 for 7 days prior to challenge (group D) suffered from diarrhea later (starting at 48 h) and recovered earlier than did group C mice. The post challenge feeding with <italic>B</italic>. <italic>thermophilum</italic> RBL67 (group E) also delayed the onset of diarrhea slightly (30 h) without accelerating recovery. Body weight was significantly lower in groups C, D and E during the first 72 h post challenge (<xref ref-type="supplementary-material" rid="pone.0164512.s002">S2 Fig</xref>).</p>
</sec>
<sec id="sec019">
<title>Pre-challenge feeding with <italic>B</italic>. <italic>thermophilum</italic> RBL67 limited intestinal replication of rotavirus</title>
<p>The course of rotavirus infection in suckling CD-1 mice was observed for 72 h by measuring strain SA-11 titer in the intestinal contents using ELISA (<xref ref-type="fig" rid="pone.0164512.g004">Fig 4</xref>). No rotavirus was detected in control mice (group A) or mice fed <italic>B</italic>. <italic>thermophilum</italic> RBL67 (group B). In mice not fed <italic>B</italic>. <italic>thermophilum</italic> RBL67 but challenged with strain SA-11 (group C), the titer increased from 2.9 log<sub>10</sub> initially, peaked to 5.2 log<sub>10</sub> after 24 h and decreased at 4.2 log<sub>10</sub> after 30 h, as described previously [<xref ref-type="bibr" rid="pone.0164512.ref049">49</xref>]. In mice that received <italic>B</italic>. <italic>thermophilum</italic> RBL67 for 7 days after challenge (group E), a 30 h delay in the increase from the initial titer (3.5 log<sub>10</sub>) was noted. The titer then rose to 4.4 log<sub>10</sub> at 72 h. Pre-challenge feeding with <italic>B</italic>. <italic>thermophilum</italic> RBL67 (group D) appeared to control the infection, limiting the rotavirus titer to between 3.2 and 2.5 log<sub>10</sub> (significantly lower than in the other groups) for 72 h.</p>
<fig id="pone.0164512.g004" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0164512.g004</object-id>
<label>Fig 4</label>
<caption>
<title>Simian rotavirus strain SA-11 titer measured in the intestinal contents of suckling CD-1 mice: challenged with the virus (group C, ✕), fed <italic>Bifidobacterium</italic> strain RBL67 before challenge (group D, ■), fed strain RBL67 after challenge (group E, ●).</title>
<p>Rotavirus titer was determined by plaque assay. Error bars indicate the standard error of the mean. An asterisk indicates statistical significance compared to <bold>✕</bold> (Hsu-Dunnett test, <italic>P</italic> &lt; 0.05, n = 3).</p>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0164512.g004" xlink:type="simple"/>
</fig>
</sec>
<sec id="sec020">
<title>Pre-challenge feeding with <italic>B</italic>. <italic>thermophilum</italic> RBL67 limited intestinal lesions</title>
<p>Inflammatory histopathology as revealed by hematoxylin and eosin stains of sections of colon from non-infected CD-1 suckling mice (groups A and B) and those challenged with simian rotavirus strain SA-11 with or without <italic>B</italic>. <italic>thermophilum</italic> RBL67 treatment (groups C, D and E) are shown in <xref ref-type="fig" rid="pone.0164512.g005">Fig 5</xref>. Colons of group B mice appeared similar to those of control mice (group A). Histological damage was observed in infected mice (group C) beginning 48 h post challenge as was accumulation of fluid in the intestine and dilated colon at necropsy, as described previously [<xref ref-type="bibr" rid="pone.0164512.ref049">49</xref>]. Post-challenge feeding with <italic>B</italic>. <italic>thermophilum</italic> RBL67 (group E) postponed the onset of visible lesions to 54 h. Group D mice showed less epithelial destruction at 6 h and 48 h, and restoration of normal colonic epithelial architecture by 54 h.</p>
<fig id="pone.0164512.g005" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0164512.g005</object-id>
<label>Fig 5</label>
<caption>
<title>Hematoxylin and eosin stains of cross-sections of colons from suckling CD-1 mice following challenge with simian rotavirus strain SA-11. Group A: not fed strain RBL67, Group C: not fed strain RBL67, challenged with rotavirus SA-11, Group D: fed strain RBL67 before challenge, Group E: fed strain RBL67 after challenge.</title>
<p>All images were obtained using the same camera setting and are shown at a magnification of 40X.</p>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0164512.g005" xlink:type="simple"/>
</fig>
</sec>
<sec id="sec021">
<title>Ingested <italic>Bifidobacterium</italic> strain RBL67 stimulated the humoral immune response in suckling mice</title>
<p>The influence of <italic>B</italic>. <italic>thermophilum</italic> RBL67 on the immune response in suckling CD-1 mice was evaluated by measuring rotavirus-specific IgA in intestinal contents and IgG and IgM in serum (<xref ref-type="fig" rid="pone.0164512.g006">Fig 6</xref>). These immunoglobulins were undetectable in mice not challenged with the virus (groups A and B). Four days after challenge with rotavirus (group C), IgA reached 1 OD unit and remained stable until day 7. Ingestion of <italic>B</italic>. <italic>thermophilum</italic> RBL67 (group D) did not change this level significantly. Among group C mice, IgG and IgM reached 2.0 OD on day 7 and rose to 2.4 OD on day 14, and were even higher (2.9 OD) among group D mice (fed <italic>B</italic>. <italic>thermophilum</italic> RBL67 for 1 week prior to challenge) from days 7 through 14. Post-challenge feeding (group E) led to the highest level measured for IgG and IgM (3.7 OD), but not until day 14.</p>
<fig id="pone.0164512.g006" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0164512.g006</object-id>
<label>Fig 6</label>
<caption>
<title>Immunoglobulin G and M production measured (by ELISA) in serum of mice 7 days (light shade) and 14 days (dark shade) after challenge with simian rotavirus strain SA-11. Group C: not fed strain RBL67, challenged with rotavirus SA-11, Group D: fed strain RBL67 before challenge, Group E: fed strain RBL67 after challenge.</title>
<p>Error bars indicate the standard error of the mean. An asterisk indicates significantly different from group C (Hsu-Dunnett test, <italic>P</italic> &lt; 0.05, n = 3).</p>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0164512.g006" xlink:type="simple"/>
</fig>
</sec>
</sec>
<sec id="sec022" sec-type="conclusions">
<title>Discussion</title>
<p>Despite the effectiveness of vaccines against rotavirus, interest in alternative therapies such as probiotics remains keen, due particularly to the high cost of the vaccine and the lack of rotavirus vaccination programs in many developing countries [<xref ref-type="bibr" rid="pone.0164512.ref034">34</xref>, <xref ref-type="bibr" rid="pone.0164512.ref050">50</xref>, <xref ref-type="bibr" rid="pone.0164512.ref051">51</xref>]. In the present study, the ability of the probiotic candidate <italic>B</italic>. <italic>thermophilum</italic> RBL67 to inhibit rotavirus infection was assessed <italic>in vitro</italic> using intestinal cell lines and then <italic>in vivo</italic> using suckling mice.</p>
<p>Prior to <italic>in vivo</italic> study, the probiotic candidate should be screened for safety, resistance to gastric acidity and bile acid, adherence to human epithelial cells, and ability to reduce pathogen adhesion [<xref ref-type="bibr" rid="pone.0164512.ref019">19</xref>]. The long history of consumption of fermented milk and the growing body of knowledge on bifidobacteria taxonomy and physiology support the safety of the proposed use of bacteria such as <italic>B</italic>. <italic>thermophilum</italic> RBL67 [<xref ref-type="bibr" rid="pone.0164512.ref052">52</xref>]. This strain has been shown resistant to acidity [<xref ref-type="bibr" rid="pone.0164512.ref032">32</xref>] and should be resistant to bile since it possesses bile salt hydrolase [<xref ref-type="bibr" rid="pone.0164512.ref040">40</xref>]. We evaluated its adhesiveness (<xref ref-type="fig" rid="pone.0164512.g001">Fig 1</xref>) to two intestinal cell lines that present different functional characteristics, namely Caco-2 and HT-29 [<xref ref-type="bibr" rid="pone.0164512.ref053">53</xref>]. Its adhesion index on Caco-2 cells is similar to that of <italic>B</italic>. <italic>animalis</italic> subsp. <italic>lactis</italic> Bb12 [<xref ref-type="bibr" rid="pone.0164512.ref054">54</xref>] and <italic>B</italic>. <italic>pseudolongum</italic> ATCC 25526, which are considered highly adhesive [<xref ref-type="bibr" rid="pone.0164512.ref048">48</xref>]. The adhesion index of <italic>B</italic>. <italic>thermophilum</italic> RBL67 was also higher than that of <italic>Lb</italic>. <italic>rhamnosus</italic> GG (the most studied probiotic), estimated at 145 [<xref ref-type="bibr" rid="pone.0164512.ref055">55</xref>]. This ability might be associated in part with the presence of enolase and transaldolase genes, revealed by sequencing of the <italic>B</italic>. <italic>thermophilum</italic> RBL67 genome [<xref ref-type="bibr" rid="pone.0164512.ref040">40</xref>], which are involved in interaction processes with the host [<xref ref-type="bibr" rid="pone.0164512.ref056">56</xref>, <xref ref-type="bibr" rid="pone.0164512.ref057">57</xref>].</p>
<p>An <italic>in vitro</italic> assay carried out to evaluate to what extent <italic>B</italic>. <italic>thermophilum</italic> RBL67 interfered with rotavirus attachment to intestinal cell lines revealed that this strain excludes rotavirus competitively. Among the three strategies tested, exclusion (contact with the cells for 30 min prior to challenge with the virus) and competition led to the greatest reductions in rotavirus attachment (<xref ref-type="fig" rid="pone.0164512.g002">Fig 2</xref>). The exclusion scenario simulates the presence of the probiotic in the intestinal lumen due to ingestion of bacteria as a supplement before infection. Rotavirus attachment was reduced by 2.0 ± 0.1 log<sub>10</sub> and 1.5 ± 0.1 log<sub>10</sub> in exclusion and competition assays respectively. To our knowledge, no such reduction has been reported previously in the literature. Reductions in the range of 9.0–49.8% (i.e. less than 1 log<sub>10</sub>) have been observed previously for human rotavirus Wa attachment to MA-104 and HT-29 cells in the presence of 6 <italic>Bifidobacterium</italic> strains, whether in exclusion or competition assays [<xref ref-type="bibr" rid="pone.0164512.ref058">58</xref>], and in the range of 3.3–38% for attachment to Vero cells in the presence of 5 <italic>Bifidobacterium</italic> or 6 <italic>Lactobacillus</italic> strains [<xref ref-type="bibr" rid="pone.0164512.ref059">59</xref>]. In the present study, the third assay (displacement) simulating post-infection feeding led to negligible reduction of rotavirus attachment (0.2 ± 0.1 log<sub>10</sub>), possibly explaining the poor health observed in group E mice.</p>
<p>Based on these results, an <italic>in vivo</italic> study was performed using suckling mice to evaluate the host-protective properties of <italic>B</italic>. <italic>thermophilum</italic> RBL67 and to determine whether or not daily intake could mitigate the risk of rotavirus infection. CD-1 suckling mice were chosen because of their susceptibility to rotavirus (induction of diarrhea and spread of the virus throughout the tissues in a reproducible manner) and they are well characterized, low cost, and easy to handle in large numbers [<xref ref-type="bibr" rid="pone.0164512.ref060">60</xref>, <xref ref-type="bibr" rid="pone.0164512.ref061">61</xref>]. Ingestion of <italic>B</italic>. <italic>thermophilum</italic> RBL67 increased significantly the concentration of viable <italic>Bifidobacterium</italic> in the intestine, confirming that this probiotic candidate of fecal origin survived the various digestive stresses. The strain persisted in the intestine only for 2 days after daily consumption ceased (<xref ref-type="fig" rid="pone.0164512.g003">Fig 3</xref>). Although <italic>B</italic>. <italic>thermophilum</italic> RBL67 has been shown to grow in a simulated human juvenile intestinal environment [<xref ref-type="bibr" rid="pone.0164512.ref038">38</xref>], it did not likely persist in the intestinal microbiota of the suckling mice, since an indigenous population of <italic>Bifidobacterium</italic> was already present. Tannock, Munro [<xref ref-type="bibr" rid="pone.0164512.ref062">62</xref>] demonstrated that a stable population of lactobacilli prevented long-term colonization by <italic>Lb</italic>. <italic>rhamnosus</italic> DR20 ingested as a probiotic. In addition, <italic>B</italic>. <italic>thermophilum</italic> RBL67 did not induce any obvious adverse or toxic effect in suckling CD-1 mice.</p>
<p>Rotavirus induced diarrhea in unprotected mice (group C) over a period of 3 days, starting at 24–30 h post challenge. The onset of this symptom coincided with the increase of viral titer in the intestinal contents (<xref ref-type="fig" rid="pone.0164512.g004">Fig 4</xref>) and the appearance of lesions in the intestinal epithelium (<xref ref-type="fig" rid="pone.0164512.g005">Fig 5</xref>). As expected [<xref ref-type="bibr" rid="pone.0164512.ref063">63</xref>, <xref ref-type="bibr" rid="pone.0164512.ref064">64</xref>], the infection triggered the production of rotavirus-specific intestinal IgA and humoral IgG and IgM. Daily ingestion of <italic>B</italic>. <italic>thermophilum</italic> RBL67 prior to infection (group D) had a moderate but clear protective effect, decreasing diarrhea and virus replication for at least 3 days. Such delays in the onset of diarrhea have been reported in association with other probiotic candidates such as <italic>B</italic>. <italic>longum</italic> [<xref ref-type="bibr" rid="pone.0164512.ref059">59</xref>] and <italic>Lb</italic>. <italic>rhamnosus</italic> GG [<xref ref-type="bibr" rid="pone.0164512.ref065">65</xref>]. In contrast, the published data concerning the control of virus shedding are discordant since this is likely strain-specific. <italic>B</italic>. <italic>longum</italic> [<xref ref-type="bibr" rid="pone.0164512.ref059">59</xref>], <italic>Lb</italic>. <italic>rhamnosus</italic> GG [<xref ref-type="bibr" rid="pone.0164512.ref065">65</xref>], <italic>Lb</italic>. <italic>acidophilus</italic> NCFM and <italic>Lb</italic>. <italic>reuteri</italic> ATCC 23272 [<xref ref-type="bibr" rid="pone.0164512.ref066">66</xref>] were reported to have no effect, unlike a combination of <italic>Lb</italic>. <italic>rhamnosus</italic> GG and <italic>B</italic>. <italic>animalis</italic> subsp. <italic>lactis</italic> Bb12, which controlled virus shedding until 4 days post challenge [<xref ref-type="bibr" rid="pone.0164512.ref067">67</xref>]. A significant initial reduction in rotavirus shedding has been noted following pre-challenge feeding with <italic>B</italic>. <italic>longum</italic> subsp. <italic>infantis</italic> CECT 7210, but this was not maintained beyond day 2 post challenge [<xref ref-type="bibr" rid="pone.0164512.ref058">58</xref>]. Daily ingestion of <italic>B</italic>. <italic>thermophilum</italic> RBL67 prior to challenge reduced damage to the intestinal epithelium, which recovered its normal architecture by 54 h post challenge. Some preservation of vacuolated enterocytes has been associated with <italic>Lb</italic>. <italic>rhamnosus</italic> GG, although normal architecture was still not restored 6 days post challenge [<xref ref-type="bibr" rid="pone.0164512.ref065">65</xref>]. Post-challenge feeding with <italic>B</italic>. <italic>thermophilum</italic> RBL67 (group E) provided less conclusive results than did pre-challenge feeding (group D), in which the increase in intestinal rotavirus titer and damage to the epithelium were limited to the 30–54 h period before returning to levels observed in control mice (group B). Nevertheless, these effects are similar to those observed with pre-challenge ingestion of <italic>B</italic>. <italic>longum</italic> subsp. <italic>infantis</italic> CECT 7210 [<xref ref-type="bibr" rid="pone.0164512.ref058">58</xref>].</p>
<p>Several mechanisms have been proposed to explain the efficacy of probiotics in the prevention and treatment of diarrheal diseases. The possible mechanisms include among others production of acidity, short-chain fatty acids and antimicrobial substances, normalization of perturbed microbiota, increased turnover of enterocytes, competitive exclusion of pathogens, improved barrier function, and stimulation of immune responses to pathogens [<xref ref-type="bibr" rid="pone.0164512.ref020">20</xref>, <xref ref-type="bibr" rid="pone.0164512.ref068">68</xref>]. The moderate protective effect associated with <italic>B</italic>. <italic>thermophilum</italic> RBL67 intake could be due partly to competitive exclusion of rotavirus, tight junction strengthening [<xref ref-type="bibr" rid="pone.0164512.ref039">39</xref>] and stimulation of the immune response. Indeed, recovery from infection is correlated primarily with rotavirus-specific antibody production [<xref ref-type="bibr" rid="pone.0164512.ref069">69</xref>]. We found no significant stimulation of IgA in response to ingestion of <italic>B</italic>. <italic>thermophilum</italic> RBL67. Regarding this immunoglobulin, conflicting results have been reported: some researchers have observed stimulation [<xref ref-type="bibr" rid="pone.0164512.ref070">70</xref>–<xref ref-type="bibr" rid="pone.0164512.ref073">73</xref>] while others did not [<xref ref-type="bibr" rid="pone.0164512.ref058">58</xref>]. However, ingestion of <italic>B</italic>. <italic>thermophilum</italic> RBL67 was associated with an obvious specific humoral response reflected in IgG and IgM (<xref ref-type="fig" rid="pone.0164512.g006">Fig 6</xref>). This was accelerated when <italic>B</italic>. <italic>thermophilum</italic> RBL67 was already present in the intestinal lumen at the time of challenge compared to when it was ingested post challenge. Others have shown that probiotic candidates <italic>Lb</italic>. <italic>acidophilus</italic> NCFM and <italic>Lb</italic>. <italic>reuteri</italic> ATCC 23272 increase total small intestinal IgM and IgG levels in rotavirus-infected gnotobiotic piglets [<xref ref-type="bibr" rid="pone.0164512.ref066">66</xref>]. These results suggest that the immunomodulatory effect of a probiotic is strain-specific [<xref ref-type="bibr" rid="pone.0164512.ref074">74</xref>]. Although IgA is thought to provide the most effective protection against rotavirus in the intestine, evidence suggests that serum IgG or IgM in sufficient quantities can reach the intestinal epithelium and provide additional protection [<xref ref-type="bibr" rid="pone.0164512.ref069">69</xref>, <xref ref-type="bibr" rid="pone.0164512.ref075">75</xref>–<xref ref-type="bibr" rid="pone.0164512.ref077">77</xref>]. This study does not exclude other modalities of host immune response, in particular the effect on cytokine-secreting cells [<xref ref-type="bibr" rid="pone.0164512.ref078">78</xref>], which should be investigated in a future study.</p>
<p>In summary, the probiotic candidate <italic>Bifidobacterium thermophilum</italic> strain RBL67 reduced the duration of diarrhea, limited epithelial lesions, controlled rotavirus replication in the intestine, stimulated the humoral specific IgG and IgM response, and shortened the time of recovery from symptoms in CD-1 suckling mice. Furthermore, <italic>B</italic>. <italic>thermophilum</italic> RBL67 displayed high adhesiveness and competitiveness and hence interference with rotavirus attachment to intestinal cells <italic>in vitro</italic>. These functions might contribute to the mechanisms underlying the moderate protective effect of <italic>B</italic>. <italic>thermophilum</italic> RBL67 against rotavirus in this model of infection. In addition, <italic>B</italic>. <italic>thermophilum</italic> RBL67 meets several criteria for probiotic bacteria: presumed safety, resistance to gastric acidity and bile acids, adherence to human epithelial cells, ability to reduce virus attachment and to reduce the symptoms of infection in suckling mice, and its genome now fully sequenced for scientific scrutiny. Further studies are required in order to identify the mechanisms underlying the apparent beneficial effects of <italic>B</italic>. <italic>thermophilum</italic> RBL67 and to confirm our results in a more human-like model (such as piglets) before proceeding with human trials. If these beneficial effects are also observed in human, a prophylaxis use of <italic>B</italic>. <italic>thermophilum</italic> RBL67 coupled with supplementary or complementary treatment during the winter seasonal peaks of gastroenteritis could be envisaged in children.</p>
</sec>
<sec id="sec023">
<title>Supporting Information</title>
<supplementary-material id="pone.0164512.s001" mimetype="application/vnd.openxmlformats-officedocument.wordprocessingml.document" position="float" xlink:href="info:doi/10.1371/journal.pone.0164512.s001" xlink:type="simple">
<label>S1 Fig</label>
<caption>
<title>Attachment of human rotavirus strain Wa to intestinal cells: (A) Caco-2, (B) HT-29.</title>
<p>Monolayers were contacted with rotavirus suspended at a titer of 6.9 log<sub>10</sub> ffu/mL and attachment was measured directly by immunofluorescence assay. Error bars indicate the standard error of the mean. Different letters indicate significant difference between assay times (Tukey’s HSD test, P &lt; 0.05, n = 3).</p>
<p>(DOCX)</p>
</caption>
</supplementary-material>
<supplementary-material id="pone.0164512.s002" mimetype="application/vnd.openxmlformats-officedocument.wordprocessingml.document" position="float" xlink:href="info:doi/10.1371/journal.pone.0164512.s002" xlink:type="simple">
<label>S2 Fig</label>
<caption>
<title>Average body weight of CD-1 suckling mice during 7 days after challenge with rotavirus SA-11: not fed strain RBL67 (group A, ◆), fed strain RBL67 (group B, ▴), not fed strain RBL67, challenged with rotavirus SA-11 (group C, ✕), fed strain RBL67 before challenge (group D, ■), fed strain RBL67 after challenge (group E, ●) (See <xref ref-type="table" rid="pone.0164512.t001">Table 1</xref> for details).</title>
<p>Error bars indicate the standard error of the mean. An asterisk indicates statistical significance compared to <bold>◆</bold> (Tukey’s HSD test, P &lt; 0.05, n = 189).</p>
<p>(DOCX)</p>
</caption>
</supplementary-material>
<supplementary-material id="pone.0164512.s003" mimetype="application/pdf" position="float" xlink:href="info:doi/10.1371/journal.pone.0164512.s003" xlink:type="simple">
<label>S1 File</label>
<caption>
<title>Data.</title>
<p>(PDF)</p>
</caption>
</supplementary-material>
</sec>
</body>
<back>
<ack>
<p>We thank Irena Kukavica-Ibrulj, Ueli Von Ah, Mélanie Pelletier, Julie Brassard and Brigitte Dubé for their skilled technical assistance and Sylvie Roy for the histological preparations.</p>
</ack>
<ref-list>
<title>References</title>
<ref id="pone.0164512.ref001"><label>1</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Bilcke</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Van Damme</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Van Ranst</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Hens</surname> <given-names>N</given-names></name>, <name name-style="western"><surname>Aerts</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Beutels</surname> <given-names>P</given-names></name>. <article-title>Estimating the incidence of symptomatic rotavirus infections: A systematic review and meta-analysis</article-title>. <source>PLoS ONE</source>. <year>2009</year>;<volume>4</volume>(<issue>6</issue>):<fpage>e6060</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1371/journal.pone.0006060" xlink:type="simple">10.1371/journal.pone.0006060</ext-link></comment> <object-id pub-id-type="pmid">19557133</object-id></mixed-citation></ref>
<ref id="pone.0164512.ref002"><label>2</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Lanata</surname> <given-names>CF</given-names></name>, <name name-style="western"><surname>Fischer-Walker</surname> <given-names>CL</given-names></name>, <name name-style="western"><surname>Olascoaga</surname> <given-names>AC</given-names></name>, <name name-style="western"><surname>Torres</surname> <given-names>CX</given-names></name>, <name name-style="western"><surname>Aryee</surname> <given-names>MJ</given-names></name>, <name name-style="western"><surname>Black</surname> <given-names>RE</given-names></name>. <article-title>Global causes of diarrheal disease mortality in children&lt; 5 years of age: A systematic review</article-title>. <source>PLoS ONE</source>. <year>2013</year>;<volume>8</volume>(<issue>9</issue>):<fpage>e72788</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1371/journal.pone.0072788" xlink:type="simple">10.1371/journal.pone.0072788</ext-link></comment> <object-id pub-id-type="pmid">24023773</object-id></mixed-citation></ref>
<ref id="pone.0164512.ref003"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">World Health Organisation. Rotavirus vaccines. WHO position paper—January 2013. <ext-link ext-link-type="uri" xlink:href="http://www.who.int/wer/2013/wer8805.pdf" xlink:type="simple">http://www.who.int/wer/2013/wer8805.pdf</ext-link>. Weekly Epidemiological Record. 2013;88th year(5):49–64.</mixed-citation></ref>
<ref id="pone.0164512.ref004"><label>4</label><mixed-citation publication-type="book" xlink:type="simple"><name name-style="western"><surname>Estes</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Greenberg</surname> <given-names>HB</given-names></name>. <chapter-title>Rotaviruses</chapter-title>. In: <name name-style="western"><surname>Knipe</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Howley</surname> <given-names>P</given-names></name>, editors. <source>Fields Virology</source>. <volume>Volume 1</volume>. <edition>6th ed</edition>. <publisher-loc>Philadelphia, PA, USA</publisher-loc>: <publisher-name>Wolters Kluwer Health/Lippincott Williams &amp; Wilkins</publisher-name>; <year>2013</year>. p. <fpage>1347</fpage>–<lpage>401</lpage>.</mixed-citation></ref>
<ref id="pone.0164512.ref005"><label>5</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Graham</surname> <given-names>DY</given-names></name>, <name name-style="western"><surname>Dufour</surname> <given-names>GR</given-names></name>, <name name-style="western"><surname>Estes</surname> <given-names>M</given-names></name>. <article-title>Minimal infective dose of rotavirus</article-title>. <source>Archives of Virology</source>. <year>1987</year>;<volume>92</volume>(<issue>3–4</issue>):<fpage>261</fpage>–<lpage>71</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1007/BF01317483" xlink:type="simple">10.1007/BF01317483</ext-link></comment> <object-id pub-id-type="pmid">3028333</object-id></mixed-citation></ref>
<ref id="pone.0164512.ref006"><label>6</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Ansari</surname> <given-names>SA</given-names></name>, <name name-style="western"><surname>Sattar</surname> <given-names>SA</given-names></name>, <name name-style="western"><surname>Springthorpe</surname> <given-names>VS</given-names></name>, <name name-style="western"><surname>Wells</surname> <given-names>GA</given-names></name>, <name name-style="western"><surname>Tostowaryk</surname> <given-names>W</given-names></name>. <article-title>Rotavirus survival on human hands and transfer of infectious virus to animate and nonporous inanimate surfaces</article-title>. <source>Journal of Clinical Microbiology</source>. <year>1988</year>;<volume>26</volume>(<issue>8</issue>):<fpage>1513</fpage>–<lpage>8</lpage>. <object-id pub-id-type="pmid">2844846</object-id></mixed-citation></ref>
<ref id="pone.0164512.ref007"><label>7</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Sattar</surname> <given-names>SA</given-names></name>, <name name-style="western"><surname>Lloyd-Evans</surname> <given-names>N</given-names></name>, <name name-style="western"><surname>Springthorpe</surname> <given-names>VS</given-names></name>, <name name-style="western"><surname>Nair</surname> <given-names>RC</given-names></name>. <article-title>Institutional outbreaks of rotavirus diarrhoea: Potential role of fomites and environmental surfaces as vehicles for virus transmission</article-title>. <source>Epidemiology &amp; Infection</source>. <year>1986</year>;<volume>96</volume>(<issue>02</issue>):<fpage>277</fpage>–<lpage>89</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1017/S0022172400066055" xlink:type="simple">10.1017/S0022172400066055</ext-link></comment> <object-id pub-id-type="pmid">3701042</object-id></mixed-citation></ref>
<ref id="pone.0164512.ref008"><label>8</label><mixed-citation publication-type="book" xlink:type="simple"><name name-style="western"><surname>King</surname> <given-names>AMQ</given-names></name>, <name name-style="western"><surname>Adams</surname> <given-names>MJ</given-names></name>, <name name-style="western"><surname>Lefkowitz</surname> <given-names>EJ</given-names></name>. <chapter-title>Family: Reoviridae</chapter-title>. In: <name name-style="western"><surname>King</surname> <given-names>AMQ</given-names></name>, <name name-style="western"><surname>Adams</surname> <given-names>MJ</given-names></name>, <name name-style="western"><surname>Carstens</surname> <given-names>EB</given-names></name>, <name name-style="western"><surname>Lefkowitz</surname> <given-names>EJ</given-names></name>, editors. <source>International Committee on Taxonomy of Viruses: Ninth Report of the International Committee on Taxonomy of Viruses, International Union of Microbiological Societies</source>. <volume>Volume 9</volume>. <publisher-loc>San Diego, CA, USA</publisher-loc>: <publisher-name>Elsevier</publisher-name>; <year>2011</year>. p. <fpage>541</fpage>–<lpage>637</lpage>.</mixed-citation></ref>
<ref id="pone.0164512.ref009"><label>9</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Arias</surname> <given-names>CF</given-names></name>, <name name-style="western"><surname>Silva-Ayala</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>López</surname> <given-names>S</given-names></name>. <article-title>Rotavirus entry: A deep journey into the cell with several exits</article-title>. <source>Journal of Virology</source>. <year>2015</year>;<volume>89</volume>(<issue>2</issue>):<fpage>890</fpage>–<lpage>3</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1128/JVI.01787-14" xlink:type="simple">10.1128/JVI.01787-14</ext-link></comment> <object-id pub-id-type="pmid">25378490</object-id></mixed-citation></ref>
<ref id="pone.0164512.ref010"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">Gavi. Rotavirus vaccine support 2015 [23 september 2015]. Available from: <ext-link ext-link-type="uri" xlink:href="http://www.gavi.org/support/nvs/rotavirus/" xlink:type="simple">http://www.gavi.org/support/nvs/rotavirus/</ext-link>.</mixed-citation></ref>
<ref id="pone.0164512.ref011"><label>11</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Clarke</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Desselberger</surname> <given-names>U</given-names></name>. <article-title>Correlates of protection against human rotavirus disease and the factors influencing protection in low-income settings</article-title>. <source>Mucosal Immunol</source>. <year>2015</year>;<volume>8</volume>(<issue>1</issue>):<fpage>1</fpage>–<lpage>17</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/mi.2014.114" xlink:type="simple">10.1038/mi.2014.114</ext-link></comment> <object-id pub-id-type="pmid">25465100</object-id></mixed-citation></ref>
<ref id="pone.0164512.ref012"><label>12</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Atchison</surname> <given-names>CJ</given-names></name>, <name name-style="western"><surname>Stowe</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Andrews</surname> <given-names>N</given-names></name>, <name name-style="western"><surname>Collins</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Allen</surname> <given-names>DJ</given-names></name>, <name name-style="western"><surname>Nawaz</surname> <given-names>S</given-names></name>, <etal>et al</etal>. <article-title>Rapid declines in age group–specific rotavirus infection and acute gastroenteritis among vaccinated and unvaccinated individuals within 1 year of rotavirus vaccine introduction in England and Wales</article-title>. <source>Journal of Infectious Diseases</source>. <year>2016</year>;<volume>213</volume>(<issue>2</issue>):<fpage>243</fpage>–<lpage>9</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1093/infdis/jiv398" xlink:type="simple">10.1093/infdis/jiv398</ext-link></comment> <object-id pub-id-type="pmid">26232438</object-id></mixed-citation></ref>
<ref id="pone.0164512.ref013"><label>13</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Robinson</surname> <given-names>CM</given-names></name>, <name name-style="western"><surname>Pfeiffer</surname> <given-names>JK</given-names></name>. <article-title>Viruses and the microbiota</article-title>. <source>Annual review of virology</source>. <year>2014</year>;<volume>1</volume>:<fpage>55</fpage>–<lpage>69</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1146/annurev-virology-031413-085550" xlink:type="simple">10.1146/annurev-virology-031413-085550</ext-link>.</comment> PMC4373533. <object-id pub-id-type="pmid">25821837</object-id></mixed-citation></ref>
<ref id="pone.0164512.ref014"><label>14</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Pfeiffer</surname> <given-names>JK</given-names></name>, <name name-style="western"><surname>Virgin</surname> <given-names>HW</given-names></name>. <article-title>Transkingdom control of viral infection and immunity in the mammalian intestine</article-title>. <source>Science</source>. <year>2016</year>;<volume>351</volume>(<issue>6270</issue>):<fpage>aad5872</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1126/science.aad5872" xlink:type="simple">10.1126/science.aad5872</ext-link></comment> <object-id pub-id-type="pmid">26816384</object-id></mixed-citation></ref>
<ref id="pone.0164512.ref015"><label>15</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Jones</surname> <given-names>MK</given-names></name>, <name name-style="western"><surname>Watanabe</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Zhu</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Graves</surname> <given-names>CL</given-names></name>, <name name-style="western"><surname>Keyes</surname> <given-names>LR</given-names></name>, <name name-style="western"><surname>Grau</surname> <given-names>KR</given-names></name>, <etal>et al</etal>. <article-title>Enteric bacteria promote human and mouse norovirus infection of B cells</article-title>. <source>Science</source>. <year>2014</year>;<volume>346</volume>(<issue>6210</issue>):<fpage>755</fpage>–<lpage>9</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1126/science.1257147" xlink:type="simple">10.1126/science.1257147</ext-link></comment> <object-id pub-id-type="pmid">25378626</object-id></mixed-citation></ref>
<ref id="pone.0164512.ref016"><label>16</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Uchiyama</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Chassaing</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>Zhang</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>Gewirtz</surname> <given-names>AT</given-names></name>. <article-title>Antibiotic treatment suppresses rotavirus infection and enhances specific humoral immunity</article-title>. <source>Journal of Infectious Diseases</source>. <year>2014</year>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1093/infdis/jiu037" xlink:type="simple">10.1093/infdis/jiu037</ext-link></comment> <object-id pub-id-type="pmid">24436449</object-id></mixed-citation></ref>
<ref id="pone.0164512.ref017"><label>17</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Allen</surname> <given-names>SJ</given-names></name>, <name name-style="western"><surname>Martinez</surname> <given-names>EG</given-names></name>, <name name-style="western"><surname>Gregorio</surname> <given-names>GV</given-names></name>, <name name-style="western"><surname>Dans</surname> <given-names>LF</given-names></name>. <article-title>Probiotics for treating acute infectious diarrhoea</article-title>. <source>Cochrane Database Systematic Reviews</source> <year>2010</year>;(<issue>11</issue>). <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1002/14651858.CD003048.pub3" xlink:type="simple">10.1002/14651858.CD003048.pub3</ext-link></comment></mixed-citation></ref>
<ref id="pone.0164512.ref018"><label>18</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Mrukowicz</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Szajewska</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Vesikari</surname> <given-names>T</given-names></name>. <article-title>Options for the prevention of rotavirus disease other than vaccination</article-title>. <source>Journal of Pediatric Gastroenterology and Nutrition</source>. <year>2008</year>;<volume>46</volume>:<fpage>S32</fpage>–<lpage>S7</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1097/MPG.0b013e31816f79b0" xlink:type="simple">10.1097/MPG.0b013e31816f79b0</ext-link>.</comment> 00005176-200805002-00005. <object-id pub-id-type="pmid">18460970</object-id></mixed-citation></ref>
<ref id="pone.0164512.ref019"><label>19</label><mixed-citation publication-type="book" xlink:type="simple"><collab>Food and Agricultural Organization of the United Nations</collab>, <collab>World Health Organization</collab>. <source>Joint FAO/WHO working group report on drafting guidelines for the evaluation of probiotics in food</source>. <publisher-name>Food and Agricultural Organization of the United Nations</publisher-name> [online]. <ext-link ext-link-type="uri" xlink:href="ftp://ftpfaoorg/es/esn/food/wgreport2pdf" xlink:type="simple">ftp://ftpfaoorg/es/esn/food/wgreport2pdf</ext-link><year>2002</year>.</mixed-citation></ref>
<ref id="pone.0164512.ref020"><label>20</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Hill</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Guarner</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Reid</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Gibson</surname> <given-names>GR</given-names></name>, <name name-style="western"><surname>Merenstein</surname> <given-names>DJ</given-names></name>, <name name-style="western"><surname>Pot</surname> <given-names>B</given-names></name>, <etal>et al</etal>. <article-title>Expert consensus document: The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic</article-title>. <source>Nature Reviews Gastroenterology &amp; Hepatology</source>. <year>2014</year>;<volume>11</volume>(<issue>8</issue>):<fpage>506</fpage>–<lpage>14</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/nrgastro.2014.66" xlink:type="simple">10.1038/nrgastro.2014.66</ext-link></comment> <object-id pub-id-type="pmid">24912386</object-id></mixed-citation></ref>
<ref id="pone.0164512.ref021"><label>21</label><mixed-citation publication-type="book" xlink:type="simple"><name name-style="western"><surname>Gagnon</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Zihler</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Chassard</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Lacroix</surname> <given-names>C</given-names></name>. <chapter-title>Ecology of probiotics and enteric protection</chapter-title>. In: <name name-style="western"><surname>Malago</surname> <given-names>JJ</given-names></name> <name name-style="western"><surname>K</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Marinsek-Logar</surname> <given-names>R.</given-names></name>, editor. <source>Probiotic Bacteria and Enteric Infections—Cytoprotection by probiotic bacteria</source>. <volume>Volume 1</volume>. <publisher-loc>New York, NY, USA</publisher-loc>: <publisher-name>Springer Science+Business Media B.V.</publisher-name>; <year>2011</year>. p. <fpage>65</fpage>–<lpage>85</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1039/c5fo01581b" xlink:type="simple">10.1039/c5fo01581b</ext-link></comment></mixed-citation></ref>
<ref id="pone.0164512.ref022"><label>22</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Gareau</surname> <given-names>MG</given-names></name>, <name name-style="western"><surname>Sherman</surname> <given-names>PM</given-names></name>, <name name-style="western"><surname>Walker</surname> <given-names>WA</given-names></name>. <article-title>Probiotics and the gut microbiota in intestinal health and disease</article-title>. <source>Nature Reviews Gastroenterology &amp; Hepatology</source>. <year>2010</year>;<volume>7</volume>(<issue>9</issue>):<fpage>503</fpage>–<lpage>14</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/nrgastro.2010.117" xlink:type="simple">10.1038/nrgastro.2010.117</ext-link></comment> <object-id pub-id-type="pmid">20664519</object-id></mixed-citation></ref>
<ref id="pone.0164512.ref023"><label>23</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Freitas</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Tavan</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Cayuela</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Diop</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Sapin</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Trugnan</surname> <given-names>G</given-names></name>. <article-title>Host‐pathogens cross‐talk. Indigenous bacteria and probiotics also play the game</article-title>. <source>Biology of the Cell</source>. <year>2003</year>;<volume>95</volume>(<issue>8</issue>):<fpage>503</fpage>–<lpage>6</lpage>. <object-id pub-id-type="pmid">14630386</object-id></mixed-citation></ref>
<ref id="pone.0164512.ref024"><label>24</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Haschke</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Wang</surname> <given-names>W</given-names></name>, <name name-style="western"><surname>Ping</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Varavithya</surname> <given-names>W</given-names></name>, <name name-style="western"><surname>Podhipak</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Rochat</surname> <given-names>F</given-names></name>, <etal>et al</etal>. <article-title>Clinical trials prove the safety and efficacy of the probiotic strain <italic>Bifidobacterium</italic> Bb12 in follow-up formula and growing-up milks</article-title>. <source>Monatsschr Kinderheilkd</source>. <year>1998</year>;<volume>146</volume>(<issue>1</issue>):<fpage>S26</fpage>–<lpage>S30</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1007/PL00014763" xlink:type="simple">10.1007/PL00014763</ext-link></comment></mixed-citation></ref>
<ref id="pone.0164512.ref025"><label>25</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Szajewska</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Skórka</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Ruszczyński</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Gieruszczak-Białek</surname> <given-names>D</given-names></name>. <article-title>Meta-analysis: <italic>Lactobacillus</italic> GG for treating acute gastroenteritis in children—updated analysis of randomised controlled trials</article-title>. <source>Alimentary Pharmacology &amp; Therapeutics</source>. <year>2013</year>;<volume>38</volume>(<issue>5</issue>):<fpage>467</fpage>–<lpage>76</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1111/apt.12403" xlink:type="simple">10.1111/apt.12403</ext-link></comment> <object-id pub-id-type="pmid">23841880</object-id></mixed-citation></ref>
<ref id="pone.0164512.ref026"><label>26</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Guandalini</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Pensabene</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Zikri</surname> <given-names>MA</given-names></name>, <name name-style="western"><surname>Dias</surname> <given-names>JA</given-names></name>, <name name-style="western"><surname>Casali</surname> <given-names>LG</given-names></name>, <name name-style="western"><surname>Hoekstra</surname> <given-names>H</given-names></name>, <etal>et al</etal>. <article-title><italic>Lactobacillus</italic> GG administered in oral rehydration solution to children with acute diarrhea: a multicenter European trial</article-title>. <source>Journal of Pediatric Gastroenterology and Nutrition</source>. <year>2000</year>;<volume>30</volume>(<issue>1</issue>):<fpage>54</fpage>–<lpage>60</lpage>. <object-id pub-id-type="pmid">10630440</object-id></mixed-citation></ref>
<ref id="pone.0164512.ref027"><label>27</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Sarker</surname> <given-names>SA</given-names></name>, <name name-style="western"><surname>Sultana</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Fuchs</surname> <given-names>GJ</given-names></name>, <name name-style="western"><surname>Alam</surname> <given-names>NH</given-names></name>, <name name-style="western"><surname>Azim</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Brüssow</surname> <given-names>H</given-names></name>, <etal>et al</etal>. <article-title><italic>Lactobacillus paracasei</italic> strain ST11 has no effect on rotavirus but ameliorates the outcome of nonrotavirus diarrhea in children from Bangladesh</article-title>. <source>Pediatrics</source>. <year>2005</year>;<volume>116</volume>(<issue>2</issue>):<fpage>e221</fpage>–<lpage>e8</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1542/peds.2004-2334" xlink:type="simple">10.1542/peds.2004-2334</ext-link></comment> <object-id pub-id-type="pmid">15995003</object-id></mixed-citation></ref>
<ref id="pone.0164512.ref028"><label>28</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Saavedra</surname> <given-names>JM</given-names></name>, <name name-style="western"><surname>Bauman</surname> <given-names>NA</given-names></name>, <name name-style="western"><surname>Perman</surname> <given-names>JA</given-names></name>, <name name-style="western"><surname>Yolken</surname> <given-names>RH</given-names></name>, <name name-style="western"><surname>Saavedra</surname> <given-names>JM</given-names></name>, <name name-style="western"><surname>Bauman</surname> <given-names>NA</given-names></name>, <etal>et al</etal>. <article-title>Feeding of <italic>Bifidobacterium bifidum</italic> and <italic>Streptococcus thermophilus</italic> to infants in hospital for prevention of diarrhoea and shedding of rotavirus</article-title>. <source>The Lancet</source>. <year>1994</year>;<volume>344</volume>(<issue>8929</issue>):<fpage>1046</fpage>–<lpage>9</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/S0140-6736(94)91708-6" xlink:type="simple">10.1016/S0140-6736(94)91708-6</ext-link></comment> <object-id pub-id-type="pmid">7934445</object-id></mixed-citation></ref>
<ref id="pone.0164512.ref029"><label>29</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kandasamy</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Vlasova</surname> <given-names>AN</given-names></name>, <name name-style="western"><surname>Fischer</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Kumar</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Chattha</surname> <given-names>KS</given-names></name>, <name name-style="western"><surname>Rauf</surname> <given-names>A</given-names></name>, <etal>et al</etal>. <article-title>Differential effects of <italic>Escherichia coli</italic> Nissle and <italic>Lactobacillus rhamnosus</italic> strain GG on human rotavirus binding, infection, and B cell immunity</article-title>. <source>The Journal of Immunology</source>. <year>2016</year>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.4049/jimmunol.1501705" xlink:type="simple">10.4049/jimmunol.1501705</ext-link></comment> <object-id pub-id-type="pmid">26800875</object-id></mixed-citation></ref>
<ref id="pone.0164512.ref030"><label>30</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Grandy</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Medina</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Soria</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Teran</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Araya</surname> <given-names>M</given-names></name>. <article-title>Probiotics in the treatment of acute rotavirus diarrhoea. A randomized, double-blind, controlled trial using two different probiotic preparations in Bolivian children</article-title>. <source>BMC Infectious Diseases</source>. <year>2010</year>;<volume>10</volume>(<issue>1</issue>):<fpage>253</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1186/1471-2334-10-253" xlink:type="simple">10.1186/1471-2334-10-253</ext-link></comment> <object-id pub-id-type="pmid">20735858</object-id></mixed-citation></ref>
<ref id="pone.0164512.ref031"><label>31</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Touré</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Kheadr</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Lacroix</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Moroni</surname> <given-names>O</given-names></name>, <name name-style="western"><surname>Fliss</surname> <given-names>I</given-names></name>. <article-title>Production of antibacterial substances by bifidobacterial isolates from infant stool active against <italic>Listeria monocytogenes</italic></article-title>. <source>Journal of Applied Microbiology</source>. <year>2003</year>;<volume>95</volume>(<issue>5</issue>):<fpage>1058</fpage>–<lpage>69</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1046/j.1365-2672.2003.02085.x" xlink:type="simple">10.1046/j.1365-2672.2003.02085.x</ext-link></comment> <object-id pub-id-type="pmid">14633035</object-id></mixed-citation></ref>
<ref id="pone.0164512.ref032"><label>32</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>von Ah</surname> <given-names>U</given-names></name>, <name name-style="western"><surname>Mozzetti</surname> <given-names>V</given-names></name>, <name name-style="western"><surname>Lacroix</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Kheadr</surname> <given-names>EE</given-names></name>, <name name-style="western"><surname>Fliss</surname> <given-names>I</given-names></name>, <name name-style="western"><surname>Meile</surname> <given-names>L</given-names></name>. <article-title>Classification of a moderately oxygen-tolerant isolate from baby faeces as <italic>Bifidobacterium thermophilum</italic></article-title>. <source>BMC microbiology</source>. <year>2007</year>;<volume>7</volume>(<issue>1</issue>):<fpage>79</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1186/1471-2180-7-79" xlink:type="simple">10.1186/1471-2180-7-79</ext-link></comment> <object-id pub-id-type="pmid">17711586</object-id></mixed-citation></ref>
<ref id="pone.0164512.ref033"><label>33</label><mixed-citation publication-type="book" xlink:type="simple"><name name-style="western"><surname>Wold</surname> <given-names>AE</given-names></name>, <name name-style="western"><surname>Adlerberth</surname> <given-names>I</given-names></name>. <chapter-title>Breast feeding and the intestinal microflora of the infant—implications for protection against infectious diseases</chapter-title>. In: <name name-style="western"><surname>Koletzko</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>Michaelsen</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Hernell</surname> <given-names>O</given-names></name>, editors. <source>Short and Long Term Effects of Breast Feeding on Child Health. Advances in Experimental Medicine and Biology</source>. <volume>478</volume>: <publisher-name>Springer</publisher-name> <publisher-loc>US</publisher-loc>; <year>2002</year>. p. <fpage>77</fpage>–<lpage>93</lpage>.<comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1007/0-306-46830-1_7" xlink:type="simple">10.1007/0-306-46830-1_7</ext-link></comment> <object-id pub-id-type="pmid">11065062</object-id></mixed-citation></ref>
<ref id="pone.0164512.ref034"><label>34</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Di Gioia</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Aloisio</surname> <given-names>I</given-names></name>, <name name-style="western"><surname>Mazzola</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Biavati</surname> <given-names>B</given-names></name>. <article-title>Bifidobacteria: their impact on gut microbiota composition and their applications as probiotics in infants</article-title>. <source>Applied Microbiology and Biotechnology</source>. <year>2014</year>;<volume>98</volume>(<issue>2</issue>):<fpage>563</fpage>–<lpage>77</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1007/s00253-013-5405-9" xlink:type="simple">10.1007/s00253-013-5405-9</ext-link></comment> <object-id pub-id-type="pmid">24287935</object-id></mixed-citation></ref>
<ref id="pone.0164512.ref035"><label>35</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Bottacini</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Ventura</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>van Sinderen</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Motherway</surname> <given-names>MOC</given-names></name>. <article-title>Diversity, ecology and intestinal function of bifidobacteria</article-title>. <source>Microbial Cell Factories</source>. <year>2014</year>;<volume>13</volume>(<issue>Suppl 1</issue>):<fpage>S4</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1186/1475-2859-13-S1-S4" xlink:type="simple">10.1186/1475-2859-13-S1-S4</ext-link></comment> <object-id pub-id-type="pmid">25186128</object-id></mixed-citation></ref>
<ref id="pone.0164512.ref036"><label>36</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kheadr</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Bernoussi</surname> <given-names>N</given-names></name>, <name name-style="western"><surname>Lacroix</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Fliss</surname> <given-names>I</given-names></name>. <article-title>Comparison of the sensitivity of commercial strains and infant isolates of bifidobacteria to antibiotics and bacteriocins</article-title>. <source>International Dairy Journal</source>. <year>2004</year>;<volume>14</volume>(<issue>12</issue>):<fpage>1041</fpage>–<lpage>53</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.idairyj.2004.04.010" xlink:type="simple">10.1016/j.idairyj.2004.04.010</ext-link></comment></mixed-citation></ref>
<ref id="pone.0164512.ref037"><label>37</label><mixed-citation publication-type="other" xlink:type="simple">von Ah U. Identification of Bifidobacterium thermophilum RBL67 isolated from baby faeces and partial purification of its bacteriocin—PhD thesis. Diss Nr 16927. Zürich, Switzerland2006.</mixed-citation></ref>
<ref id="pone.0164512.ref038"><label>38</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Zihler</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Blay</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Chassard</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Braegger</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Lacroix</surname> <given-names>C</given-names></name>. <article-title><italic>Bifidobacterium thermophilum</italic> RBL67 inhibits <italic>Salmonella enterica</italic> Serovar Typhimurium in an <italic>in vitro</italic> intestinal fermentation model</article-title>. <source>Journal of Food &amp; Nutritional Disorders</source>. <year>2014</year>;S1-003. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.4172/2324-9323.S1-003" xlink:type="simple">10.4172/2324-9323.S1-003</ext-link></comment></mixed-citation></ref>
<ref id="pone.0164512.ref039"><label>39</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Zihler</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Gagnon</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Chassard</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Lacroix</surname> <given-names>C</given-names></name>. <article-title>Protective effect of probiotics on <italic>Salmonella</italic> infectivity assessed with combined <italic>in vitro</italic> gut fermentation-cellular models</article-title>. <source>BMC Microbiology</source>. <year>2011</year>;<volume>11</volume>(<issue>1</issue>):<fpage>1</fpage>–<lpage>13</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1186/1471-2180-11-264" xlink:type="simple">10.1186/1471-2180-11-264</ext-link></comment> <object-id pub-id-type="pmid">22171685</object-id></mixed-citation></ref>
<ref id="pone.0164512.ref040"><label>40</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Jans</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Lacroix</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Follador</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Stevens</surname> <given-names>MJ</given-names></name>. <article-title>Complete genome sequence of the probiotic <italic>Bifidobacterium thermophilum</italic> strain RBL67</article-title>. <source>Genome announcements</source>. <year>2013</year>;<volume>1</volume>(<issue>3</issue>):<fpage>e00191</fpage>–<lpage>13</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1128/genomeA.00191-13" xlink:type="simple">10.1128/genomeA.00191-13</ext-link></comment> <object-id pub-id-type="pmid">23640377</object-id></mixed-citation></ref>
<ref id="pone.0164512.ref041"><label>41</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Gagnon</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Kheadr</surname> <given-names>EE</given-names></name>, <name name-style="western"><surname>Le Blay</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Fliss</surname> <given-names>I</given-names></name>. <article-title><italic>In vitro</italic> inhibition of <italic>Escherichia coli</italic> O157:H7 by bifidobacterial strains of human origin</article-title>. <source>International Journal of Food Microbiology</source>. <year>2004</year>;<volume>92</volume>(<issue>1</issue>):<fpage>69</fpage>–<lpage>78</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.ijfoodmicro.2003.07.010" xlink:type="simple">10.1016/j.ijfoodmicro.2003.07.010</ext-link></comment> <object-id pub-id-type="pmid">15033269</object-id></mixed-citation></ref>
<ref id="pone.0164512.ref042"><label>42</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Beerens</surname> <given-names>H</given-names></name>. <article-title>An elective and selective isolation medium for <italic>Bifidobacterium</italic> spp</article-title>. <source>Letters in Applied Microbiology</source>. <year>1990</year>;<volume>11</volume>(<issue>3</issue>):<fpage>155</fpage>–<lpage>7</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1111/j.1472-765X.1990.tb00148.x" xlink:type="simple">10.1111/j.1472-765X.1990.tb00148.x</ext-link></comment></mixed-citation></ref>
<ref id="pone.0164512.ref043"><label>43</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Jean</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Blais</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>Darveau</surname> <given-names>A</given-names></name>. <article-title>Rapid detection of human rotavirus using colorimetric nucleic acid sequence-based amplification (NASBA)–enzyme-linked immunosorbent assay in sewage treatment effluent</article-title>. <source>FEMS microbiology letters</source>. <year>2002</year>;<volume>210</volume>(<issue>1</issue>):<fpage>143</fpage>–<lpage>7</lpage>. <object-id pub-id-type="pmid">12023091</object-id></mixed-citation></ref>
<ref id="pone.0164512.ref044"><label>44</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Ramia</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Sattar</surname> <given-names>SA</given-names></name>. <article-title>Simian rotavirus SA-11 plaque formation in the presence of trypsin</article-title>. <source>Journal of Clinical Microbiology</source>. <year>1979</year>;<volume>10</volume>(<issue>5</issue>):<fpage>609</fpage>–<lpage>14</lpage>. <object-id pub-id-type="pmid">94597</object-id></mixed-citation></ref>
<ref id="pone.0164512.ref045"><label>45</label><mixed-citation publication-type="book" xlink:type="simple"><collab>Canadian Council on Animal Care</collab>. <source>Guide to the Care and Use of Experimental Animals</source>. <edition>2nd ed</edition>. <name name-style="western"><surname>Olfert</surname> <given-names>ED</given-names></name> <name name-style="western"><surname>C</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>McWilliam</surname> <given-names>AA</given-names></name>, editor. <publisher-loc>Ottawa, ON, Canada</publisher-loc>: <publisher-name>CCAC Press</publisher-name>; <year>1993</year>. <fpage>1</fpage>–<lpage>232</lpage> p.</mixed-citation></ref>
<ref id="pone.0164512.ref046"><label>46</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Gagnon</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Kheadr</surname> <given-names>EE</given-names></name>, <name name-style="western"><surname>Dabour</surname> <given-names>N</given-names></name>, <name name-style="western"><surname>Richard</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Fliss</surname> <given-names>I</given-names></name>. <article-title>Effect of <italic>Bifidobacterium thermacidophilum</italic> probiotic feeding on enterohemorrhagic <italic>Escherichia coli</italic> O157:H7 infection in BALB/c mice</article-title>. <source>International Journal of Food Microbiology</source>. <year>2006</year>;<volume>111</volume>(<issue>1</issue>):<fpage>26</fpage>–<lpage>33</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.ijfoodmicro.2006.04.041" xlink:type="simple">10.1016/j.ijfoodmicro.2006.04.041</ext-link></comment> <object-id pub-id-type="pmid">16822570</object-id></mixed-citation></ref>
<ref id="pone.0164512.ref047"><label>47</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Shu</surname> <given-names>Q</given-names></name>, <name name-style="western"><surname>Gill</surname> <given-names>HS</given-names></name>. <article-title>A dietary probiotic (<italic>Bifidobacterium lactis</italic> HN019) reduces the severity of <italic>Escherichia coli</italic> O157:H7 infection in mice</article-title>. <source>Medical microbiology and immunology</source>. <year>2001</year>;<volume>189</volume>(<issue>3</issue>):<fpage>147</fpage>–<lpage>52</lpage>. <object-id pub-id-type="pmid">11388612</object-id></mixed-citation></ref>
<ref id="pone.0164512.ref048"><label>48</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Crociani</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Grill</surname> <given-names>JP</given-names></name>, <name name-style="western"><surname>Huppert</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Ballongue</surname> <given-names>J</given-names></name>. <article-title>Adhesion of different bifidobacteria strains to human enterocyte-like Caco-2 cells and comparison with <italic>in vivo</italic> study</article-title>. <source>Letters in Applied Microbiology</source>. <year>1995</year>;<volume>21</volume>(<issue>3</issue>):<fpage>146</fpage>–<lpage>8</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1111/j.1472-765X.1995.tb01027.x" xlink:type="simple">10.1111/j.1472-765X.1995.tb01027.x</ext-link></comment> <object-id pub-id-type="pmid">7576496</object-id></mixed-citation></ref>
<ref id="pone.0164512.ref049"><label>49</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Boshuizen</surname> <given-names>JA</given-names></name>, <name name-style="western"><surname>Reimerink</surname> <given-names>JHJ</given-names></name>, <name name-style="western"><surname>Korteland-van Male</surname> <given-names>AM</given-names></name>, <name name-style="western"><surname>van Ham</surname> <given-names>VJJ</given-names></name>, <name name-style="western"><surname>Koopmans</surname> <given-names>MPG</given-names></name>, <name name-style="western"><surname>Büller</surname> <given-names>HA</given-names></name>, <etal>et al</etal>. <article-title>Changes in small intestinal homeostasis, morphology, and gene expression during rotavirus infection of infant mice</article-title>. <source>Journal of Virology</source>. <year>2003</year>;<volume>77</volume>(<issue>24</issue>):<fpage>13005</fpage>–<lpage>16</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1128/jvi.77.24.13005-13016.2003" xlink:type="simple">10.1128/jvi.77.24.13005-13016.2003</ext-link></comment> <object-id pub-id-type="pmid">14645557</object-id></mixed-citation></ref>
<ref id="pone.0164512.ref050"><label>50</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Colbère-Garapin</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Martin-Latil</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Blondel</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>Mousson</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Pelletier</surname> <given-names>I</given-names></name>, <name name-style="western"><surname>Autret</surname> <given-names>A</given-names></name>, <etal>et al</etal>. <article-title>Prevention and treatment of enteric viral infections: possible benefits of probiotic bacteria</article-title>. <source>Microbes and Infection</source>. <year>2007</year>;<volume>9</volume>(<issue>14</issue>):<fpage>1623</fpage>–<lpage>31</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.micinf.2007.09.016" xlink:type="simple">10.1016/j.micinf.2007.09.016</ext-link></comment> <object-id pub-id-type="pmid">18023231</object-id></mixed-citation></ref>
<ref id="pone.0164512.ref051"><label>51</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Picard</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Fioramonti</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Francois</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Robinson</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Neant</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Matuchansky</surname> <given-names>C</given-names></name>. <article-title>Review article: Bifidobacteria as probiotic agents—physiological effects and clinical benefits</article-title>. <source>Alimentary Pharmacology &amp; Therapeutics</source>. <year>2005</year>;<volume>22</volume>(<issue>6</issue>):<fpage>495</fpage>–<lpage>512</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1111/j.1365-2036.2005.02615.x" xlink:type="simple">10.1111/j.1365-2036.2005.02615.x</ext-link></comment> <object-id pub-id-type="pmid">16167966</object-id></mixed-citation></ref>
<ref id="pone.0164512.ref052"><label>52</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Russell</surname> <given-names>DA</given-names></name>, <name name-style="western"><surname>Ross</surname> <given-names>RP</given-names></name>, <name name-style="western"><surname>Fitzgerald</surname> <given-names>GF</given-names></name>, <name name-style="western"><surname>Stanton</surname> <given-names>C</given-names></name>. <article-title>Metabolic activities and probiotic potential of bifidobacteria</article-title>. <source>International Journal of Food Microbiology</source>. <year>2011</year>;<volume>149</volume>(<issue>1</issue>):<fpage>88</fpage>–<lpage>105</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.ijfoodmicro.2011.06.003" xlink:type="simple">10.1016/j.ijfoodmicro.2011.06.003</ext-link></comment> <object-id pub-id-type="pmid">21763022</object-id></mixed-citation></ref>
<ref id="pone.0164512.ref053"><label>53</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Gagnon</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Zihler Berner</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Chervet</surname> <given-names>N</given-names></name>, <name name-style="western"><surname>Chassard</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Lacroix</surname> <given-names>C</given-names></name>. <article-title>Comparison of the Caco-2, HT-29 and the mucus-secreting HT29-MTX intestinal cell models to investigate <italic>Salmonella</italic> adhesion and invasion</article-title>. <source>Journal of Microbiological Methods</source>. <year>2013</year>;<volume>94</volume>(<issue>3</issue>):<fpage>274</fpage>–<lpage>9</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.mimet.2013.06.027" xlink:type="simple">10.1016/j.mimet.2013.06.027</ext-link></comment> <object-id pub-id-type="pmid">23835135</object-id></mixed-citation></ref>
<ref id="pone.0164512.ref054"><label>54</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Serafini</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Strati</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Ruas-Madiedo</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Turroni</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Foroni</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Duranti</surname> <given-names>S</given-names></name>, <etal>et al</etal>. <article-title>Evaluation of adhesion properties and antibacterial activities of the infant gut commensal <italic>Bifidobacterium bifidum</italic> PRL2010</article-title>. <source>Anaerobe</source>. <year>2013</year>;<volume>21</volume>:<fpage>9</fpage>–<lpage>17</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.anaerobe.2013.03.003" xlink:type="simple">10.1016/j.anaerobe.2013.03.003</ext-link></comment> <object-id pub-id-type="pmid">23523946</object-id></mixed-citation></ref>
<ref id="pone.0164512.ref055"><label>55</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Gopal</surname> <given-names>PK</given-names></name>, <name name-style="western"><surname>Prasad</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Smart</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Gill</surname> <given-names>HS</given-names></name>. <article-title><italic>In vitro</italic> adherence properties of <italic>Lactobacillus rhamnosus</italic> DR20 and <italic>Bifidobacterium lactis</italic> DR10 strains and their antagonistic activity against an enterotoxigenic <italic>Escherichia coli</italic></article-title>. <source>International Journal of Food Microbiology</source>. <year>2001</year>;<volume>67</volume>(<issue>3</issue>):<fpage>207</fpage>–<lpage>16</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/S0168-1605(01)00440-8" xlink:type="simple">10.1016/S0168-1605(01)00440-8</ext-link></comment> <object-id pub-id-type="pmid">11518430</object-id></mixed-citation></ref>
<ref id="pone.0164512.ref056"><label>56</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Candela</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Biagi</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Centanni</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Turroni</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Vici</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Musiani</surname> <given-names>F</given-names></name>, <etal>et al</etal>. <article-title>Bifidobacterial enolase, a cell surface receptor for human plasminogen involved in the interaction with the host</article-title>. <source>Microbiology</source>. <year>2009</year>;<volume>155</volume>(<issue>10</issue>):<fpage>3294</fpage>–<lpage>303</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1099/mic.0.028795-0" xlink:type="simple">10.1099/mic.0.028795-0</ext-link></comment> <object-id pub-id-type="pmid">19574304</object-id></mixed-citation></ref>
<ref id="pone.0164512.ref057"><label>57</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>González-Rodríguez</surname> <given-names>I</given-names></name>, <name name-style="western"><surname>Sánchez</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>Ruiz</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Turroni</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Ventura</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Ruas-Madiedo</surname> <given-names>P</given-names></name>, <etal>et al</etal>. <article-title>Role of extracellular transaldolase from <italic>Bifidobacterium bifidum</italic> in mucin adhesion and aggregation</article-title>. <source>Applied and Environmental Microbiology</source>. <year>2012</year>;<volume>78</volume>(<issue>11</issue>):<fpage>3992</fpage>–<lpage>8</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1128/aem.08024-11" xlink:type="simple">10.1128/aem.08024-11</ext-link></comment> <object-id pub-id-type="pmid">22447584</object-id></mixed-citation></ref>
<ref id="pone.0164512.ref058"><label>58</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Moreno Muñoz</surname> <given-names>JA</given-names></name>, <name name-style="western"><surname>Chenoll</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Casinos</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>Bataller</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Ramón</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Genovés</surname> <given-names>S</given-names></name>, <etal>et al</etal>. <article-title>Novel probiotic <italic>Bifidobacterium longum</italic> subsp. <italic>infantis</italic> CECT 7210 strain active against rotavirus infections</article-title>. <source>Applied and Environmental Microbiology</source>. <year>2011</year>;<volume>77</volume>(<issue>24</issue>):<fpage>8775</fpage>–<lpage>83</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1128/aem.05548-11" xlink:type="simple">10.1128/aem.05548-11</ext-link></comment> <object-id pub-id-type="pmid">22003027</object-id></mixed-citation></ref>
<ref id="pone.0164512.ref059"><label>59</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Lee</surname> <given-names>DK</given-names></name>, <name name-style="western"><surname>Park</surname> <given-names>JE</given-names></name>, <name name-style="western"><surname>Kim</surname> <given-names>MJ</given-names></name>, <name name-style="western"><surname>Seo</surname> <given-names>JG</given-names></name>, <name name-style="western"><surname>Lee</surname> <given-names>JH</given-names></name>, <name name-style="western"><surname>Ha</surname> <given-names>NJ</given-names></name>. <article-title>Probiotic bacteria, <italic>B</italic>. <italic>longum</italic> and <italic>L</italic>. <italic>acidophilus</italic> inhibit infection by rotavirus <italic>in vitro</italic> and decrease the duration of diarrhea in pediatric patients</article-title>. <source>Clinics and Research in Hepatology and Gastroenterology</source>. <year>2015</year>;<volume>39</volume>(<issue>2</issue>):<fpage>237</fpage>–<lpage>44</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.clinre.2014.09.006" xlink:type="simple">10.1016/j.clinre.2014.09.006</ext-link></comment> <object-id pub-id-type="pmid">25459995</object-id></mixed-citation></ref>
<ref id="pone.0164512.ref060"><label>60</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Offit</surname> <given-names>PA</given-names></name>, <name name-style="western"><surname>Clark</surname> <given-names>HF</given-names></name>, <name name-style="western"><surname>Kornstein</surname> <given-names>MJ</given-names></name>, <name name-style="western"><surname>Plotkin</surname> <given-names>SA</given-names></name>. <article-title>A murine model for oral infection with a primate rotavirus (simian SA11)</article-title>. <source>Journal of Virology</source>. <year>1984</year>;<volume>51</volume>(<issue>1</issue>):<fpage>233</fpage>–<lpage>6</lpage>. <object-id pub-id-type="pmid">6328042</object-id></mixed-citation></ref>
<ref id="pone.0164512.ref061"><label>61</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Burns</surname> <given-names>JW</given-names></name>, <name name-style="western"><surname>Krishnaney</surname> <given-names>AA</given-names></name>, <name name-style="western"><surname>Vo</surname> <given-names>PT</given-names></name>, <name name-style="western"><surname>Rouse</surname> <given-names>RV</given-names></name>, <name name-style="western"><surname>Anderson</surname> <given-names>LJ</given-names></name>, <name name-style="western"><surname>Greenberg</surname> <given-names>HB</given-names></name>. <article-title>Analyses of homologous rotavirus infection in the mouse model</article-title>. <source>Virology</source>. <year>1995</year>;<volume>207</volume>(<issue>1</issue>):<fpage>143</fpage>–<lpage>53</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1006/viro.1995.1060" xlink:type="simple">10.1006/viro.1995.1060</ext-link></comment> <object-id pub-id-type="pmid">7871723</object-id></mixed-citation></ref>
<ref id="pone.0164512.ref062"><label>62</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Tannock</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Munro</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Harmsen</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Welling</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Smart</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Gopal</surname> <given-names>P</given-names></name>. <article-title>Analysis of the fecal microflora of human subjects consuming a probiotic product containing <italic>Lactobacillus rhamnosus</italic> DR20</article-title>. <source>Applied and environmental microbiology</source>. <year>2000</year>;<volume>66</volume>(<issue>6</issue>):<fpage>2578</fpage>–<lpage>88</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1128/AEM.66.6.2578-2588.2000" xlink:type="simple">10.1128/AEM.66.6.2578-2588.2000</ext-link></comment><object-id pub-id-type="pmid">10831441</object-id></mixed-citation></ref>
<ref id="pone.0164512.ref063"><label>63</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Franco</surname> <given-names>MA</given-names></name>, <name name-style="western"><surname>Greenberg</surname> <given-names>HB</given-names></name>. <article-title>Immunity to rotavirus in T cell deficient mice</article-title>. <source>Virology</source>. <year>1997</year>;<volume>238</volume>(<issue>2</issue>):<fpage>169</fpage>–<lpage>79</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1006/viro.1997.8843" xlink:type="simple">10.1006/viro.1997.8843</ext-link></comment> <object-id pub-id-type="pmid">9400590</object-id></mixed-citation></ref>
<ref id="pone.0164512.ref064"><label>64</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Baumgarth</surname> <given-names>N</given-names></name>, <name name-style="western"><surname>Tung</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Herzenberg</surname> <given-names>L</given-names></name>. <article-title>Inherent specificities in natural antibodies: a key to immune defense against pathogen invasion</article-title>. <source>Springer Semin Immun</source>. <year>2005</year>;<volume>26</volume>(<issue>4</issue>):<fpage>347</fpage>–<lpage>62</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1007/s00281-004-0182-2" xlink:type="simple">10.1007/s00281-004-0182-2</ext-link></comment> <object-id pub-id-type="pmid">15633017</object-id></mixed-citation></ref>
<ref id="pone.0164512.ref065"><label>65</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Liu</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Li</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Wen</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Wu</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Zhang</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Bui</surname> <given-names>T</given-names></name>, <etal>et al</etal>. <article-title><italic>Lactobacillus rhamnosus</italic> GG on rotavirus-induced injury of ileal epithelium in gnotobiotic pigs</article-title>. <source>Journal of Pediatric Gastroenterology and Nutrition</source>. <year>2013</year>;<volume>57</volume>(<issue>6</issue>):<fpage>750</fpage>–<lpage>8</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1097/MPG.0b013e3182a356e1" xlink:type="simple">10.1097/MPG.0b013e3182a356e1</ext-link></comment> <object-id pub-id-type="pmid">24280990</object-id></mixed-citation></ref>
<ref id="pone.0164512.ref066"><label>66</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Zhang</surname> <given-names>W</given-names></name>, <name name-style="western"><surname>Azevedo</surname> <given-names>MS</given-names></name>, <name name-style="western"><surname>Gonzalez</surname> <given-names>AM</given-names></name>, <name name-style="western"><surname>Saif</surname> <given-names>LJ</given-names></name>, <name name-style="western"><surname>Van Nguyen</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Wen</surname> <given-names>K</given-names></name>, <etal>et al</etal>. <article-title>Influence of probiotic Lactobacilli colonization on neonatal B cell responses in a gnotobiotic pig model of human rotavirus infection and disease</article-title>. <source>Veterinary Immunology and Immunopathology</source>. <year>2008</year>;<volume>122</volume>(<issue>1</issue>):<fpage>175</fpage>–<lpage>81</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.vetimm.2007.10.003" xlink:type="simple">10.1016/j.vetimm.2007.10.003</ext-link></comment> <object-id pub-id-type="pmid">18023882</object-id></mixed-citation></ref>
<ref id="pone.0164512.ref067"><label>67</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Vlasova</surname> <given-names>AN</given-names></name>, <name name-style="western"><surname>Chattha</surname> <given-names>KS</given-names></name>, <name name-style="western"><surname>Kandasamy</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Liu</surname> <given-names>Z</given-names></name>, <name name-style="western"><surname>Esseili</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Shao</surname> <given-names>L</given-names></name>, <etal>et al</etal>. <article-title>Lactobacilli and bifidobacteria promote immune homeostasis by modulating innate immune responses to human rotavirus in neonatal gnotobiotic pigs</article-title>. <source>PLoS ONE</source>. <year>2013</year>;<volume>8</volume>(<issue>10</issue>):<fpage>e76962</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1371/journal.pone.0076962" xlink:type="simple">10.1371/journal.pone.0076962</ext-link></comment> <object-id pub-id-type="pmid">24098572</object-id></mixed-citation></ref>
<ref id="pone.0164512.ref068"><label>68</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>O'Toole</surname> <given-names>PW</given-names></name>, <name name-style="western"><surname>Cooney</surname> <given-names>JC</given-names></name>. <article-title>Probiotic bacteria influence the composition and function of the intestinal microbiota</article-title>. <source>Interdisciplinary Perspectives on Infectious Diseases</source>. <year>2008</year>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1155/2008/175285" xlink:type="simple">10.1155/2008/175285</ext-link></comment></mixed-citation></ref>
<ref id="pone.0164512.ref069"><label>69</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Franco</surname> <given-names>MA</given-names></name>, <name name-style="western"><surname>Angel</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Greenberg</surname> <given-names>HB</given-names></name>. <article-title>Immunity and correlates of protection for rotavirus vaccines</article-title>. <source>Vaccine</source>. <year>2006</year>;<volume>24</volume>(<issue>15</issue>):<fpage>2718</fpage>–<lpage>31</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.vaccine.2005.12.048" xlink:type="simple">10.1016/j.vaccine.2005.12.048</ext-link></comment> <object-id pub-id-type="pmid">16446014</object-id></mixed-citation></ref>
<ref id="pone.0164512.ref070"><label>70</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Qiao</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Duffy</surname> <given-names>LC</given-names></name>, <name name-style="western"><surname>Griffiths</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Dryja</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Leavens</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Rossman</surname> <given-names>J</given-names></name>, <etal>et al</etal>. <article-title>Immune responses in rhesus rotavirus-challenged BALB/c mice treated with bifidobacteria and prebiotic supplements</article-title>. <source>Pediatric Research</source>. <year>2002</year>;<volume>51</volume>(<issue>6</issue>):<fpage>750</fpage>–<lpage>5</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1203/00006450-200206000-00015" xlink:type="simple">10.1203/00006450-200206000-00015</ext-link></comment> <object-id pub-id-type="pmid">12032272</object-id></mixed-citation></ref>
<ref id="pone.0164512.ref071"><label>71</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Mohan</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Koebnick</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Schildt</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Mueller</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Radke</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Blaut</surname> <given-names>M</given-names></name>. <article-title>Effects of <italic>Bifidobacterium lactis</italic> Bb12 supplementation on body weight, fecal pH, acetate, lactate, calprotectin, and IgA in preterm infants</article-title>. <source>Pediatric Research</source>. <year>2008</year>;<volume>64</volume>(<issue>4</issue>):<fpage>418</fpage>–<lpage>22</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1203/PDR.0b013e318181b7fa" xlink:type="simple">10.1203/PDR.0b013e318181b7fa</ext-link></comment> <object-id pub-id-type="pmid">18552710</object-id></mixed-citation></ref>
<ref id="pone.0164512.ref072"><label>72</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Fukushima</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Kawata</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Hara</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Terada</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Mitsuoka</surname> <given-names>T</given-names></name>. <article-title>Effect of a probiotic formula on intestinal immunoglobulin A production in healthy children</article-title>. <source>International Journal of Food Microbiology</source>. <year>1998</year>;<volume>42</volume>(<issue>1–2</issue>):<fpage>39</fpage>–<lpage>44</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/S0168-1605(98)00056-7" xlink:type="simple">10.1016/S0168-1605(98)00056-7</ext-link></comment> <object-id pub-id-type="pmid">9706796</object-id></mixed-citation></ref>
<ref id="pone.0164512.ref073"><label>73</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Yasui</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Kiyoshima</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Ushijima</surname> <given-names>H</given-names></name>. <article-title>Passive protection against rotavirus-induced diarrhea of mouse pups born to and nursed by dams fed <italic>Bifidobacterium breve</italic> YIT4064</article-title>. <source>The Journal of Infectious Diseases</source>. <year>1995</year>;<volume>172</volume>(<issue>2</issue>):<fpage>403</fpage>–<lpage>9</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.2307/30135785" xlink:type="simple">10.2307/30135785</ext-link></comment> <object-id pub-id-type="pmid">7622883</object-id></mixed-citation></ref>
<ref id="pone.0164512.ref074"><label>74</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Ashraf</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Shah</surname> <given-names>NP</given-names></name>. <article-title>Immune system stimulation by probiotic microorganisms</article-title>. <source>Critical Reviews in Food Science and Nutrition</source>. <year>2013</year>;<volume>54</volume>(<issue>7</issue>):<fpage>938</fpage>–<lpage>56</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1080/10408398.2011.619671" xlink:type="simple">10.1080/10408398.2011.619671</ext-link></comment> <object-id pub-id-type="pmid">24499072</object-id></mixed-citation></ref>
<ref id="pone.0164512.ref075"><label>75</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>O'Neal</surname> <given-names>CM</given-names></name>, <name name-style="western"><surname>Harriman</surname> <given-names>GR</given-names></name>, <name name-style="western"><surname>Conner</surname> <given-names>ME</given-names></name>. <article-title>Protection of the villus epithelial cells of the small intestine from rotavirus infection does not require immunoglobulin A</article-title>. <source>Journal of Virology</source>. <year>2000</year>;<volume>74</volume>(<issue>9</issue>):<fpage>4102</fpage>–<lpage>9</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1128/jvi.74.9.4102–4109.2000" xlink:type="simple">10.1128/jvi.74.9.4102–4109.2000</ext-link></comment> <object-id pub-id-type="pmid">10756022</object-id></mixed-citation></ref>
<ref id="pone.0164512.ref076"><label>76</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Istrate</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Hinkula</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Hammarström</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Svensson</surname> <given-names>L</given-names></name>. <article-title>Individuals with selective IgA deficiency resolve rotavirus disease and develop higher antibody titers (IgG, IgG1) than IgA competent individuals</article-title>. <source>Journal of Medical Virology</source>. <year>2008</year>;<volume>80</volume>(<issue>3</issue>):<fpage>531</fpage>–<lpage>5</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1002/jmv.21101" xlink:type="simple">10.1002/jmv.21101</ext-link></comment> <object-id pub-id-type="pmid">18205219</object-id></mixed-citation></ref>
<ref id="pone.0164512.ref077"><label>77</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Cerutti</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Rescigno</surname> <given-names>M</given-names></name>. <article-title>The biology of intestinal immunoglobulin A responses</article-title>. <source>Immunity</source>. <year>2008</year>;<volume>28</volume>(<issue>6</issue>):<fpage>740</fpage>–<lpage>50</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.immuni.2008.05.001" xlink:type="simple">10.1016/j.immuni.2008.05.001</ext-link></comment> <object-id pub-id-type="pmid">18549797</object-id></mixed-citation></ref>
<ref id="pone.0164512.ref078"><label>78</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Servin</surname> <given-names>AL</given-names></name>. <article-title>Antagonistic activities of lactobacilli and bifidobacteria against microbial pathogens</article-title>. <source>FEMS Microbiology Reviews</source>. <year>2004</year>;<volume>28</volume>(<issue>4</issue>):<fpage>405</fpage>–<lpage>40</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.femsre.2004.01.003" xlink:type="simple">10.1016/j.femsre.2004.01.003</ext-link></comment> <object-id pub-id-type="pmid">15374659</object-id></mixed-citation></ref>
</ref-list>
</back>
</article>